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ABSTRACT 
Marcus R. Breese 
Identification of putative targets of Nkx2-5 in Xenopus laevis using cross-species 
annotation and microarray gene expression analysis 
 
The heart is the first organ to form during development in vertebrates and Nkx2-5 is the 
first marker of cardiac specification. In Xenopus laevis, Nkx2-5 is essential for heart 
formation, but early targets of this homeodomain transcription factor have not been fully 
characterized. In order to discover potential early targets of Nkx2-5, synthetic Nkx2-5 
mRNA was injected into eight-cell Xenopus laevis embryos and changes in gene 
expression measured using microarray analysis. While Xenopus laevis is a commonly 
used model organism for developmental studies, its genome remains poorly annotated. 
To compensate for this, a cross-species annotation database called CrossGene was 
constructed. CrossGene was created by exhaustively comparing UniGene transcripts from 
Homo sapiens, Mus musculus, Rattus norvegicus, Gallus gallus, Xenopus laevis, Danio 
rerio, Drosophila melanogaster, and Caenorhabditis elegans using the BLAST family of 
algorithms. Networks were then assembled by recursively combining reciprocal best 
matches into groups of orthologous genes. Gene ontology annotation from all organisms 
could then be applied to all members of the reciprocal group. In this way, the CrossGene 
database was used to augment the existing genomic annotation of Xenopus laevis. 
vii 
Combining cross-species annotation with differential gene expression analysis of Nkx2-5 
overexpression led to the discovery of 99 potential targets of Nkx2-5. 
 
     
Howard J. Edenberg, Ph.D., Chair 
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 CHAPTER 1: INTRODUCTION 
Cardiogenesis 
The heart is the first major organ to develop and it does so via a well-coordinated series 
of events including timed changes in gene expression and cellular migration. The 
mechanisms of heart development are similar for all vertebrates, indicating that the 
developmental mechanisms are highly conserved evolutionarily. Indeed, the mechanisms 
for heart development are so well conserved that much of the early work in the field was 
performed by studying the formation of the Drosophila equivalent of the vertebrate heart, 
the dorsal vessel (Zaffran et al. 2002). Cells first become specified to the cardiac lineage 
soon after gastrulation (Srivastava et al. 2000) when mesoderm cells migrate laterally to 
form a cardiac field (or crescent) (Harvey et al. 2002).  
Subtle mutations in cardiogenic genes can have a profound effect on the formation of the 
heart. Some of these mutations result in congenital heart disease. Congenital heart defects 
are the most common cause of death for infants, amounting to almost one third of all 
deaths due to a congenital condition (Lloyd-Jones et al. 2010). It is estimated that heart 
defects are present in nearly 1% of live births, of which approximately 2.3 out of 1000 
will require some form of invasive treatment (Lloyd-Jones et al. 2010). Defects can range 
from asymptomatic ventricular septal defects that resolve themselves spontaneously to 
more major anatomical defect that require surgical intervention, including tetralogy of 
Fallot, transposition of the great arteries, atrioventricular defects, and severe ventricular 
septal defects. Mutations in several genes have been directly implicated in congenital 
heart disease in humans, these genes include Nkx2-5 (Schott et al. 1998; Benson et al. 
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 1999), TBX5 (Basson et al. 1999), and Jagged1 (Krantz et al. 1999). Studies in Mus 
musculus, Xenopus laevis, Danio rerio, and other organisms, have uncovered mutations 
in additional genes that have been linked to cardiac malformations; these include TGF-! 
(Brown et al.), GATA4 (Kuo et al. 1997; Molkentin et al. 1997), GATA5 (Reiter et al. 
1999), dHand (Srivastava et al. 1997), Nkx2-5 (Schott et al. 1998), Smad6 (Galvin et al. 
2000), and Pax3 (Conway et al. 1997a; Conway et al. 1997b). Nkx2-5 is particularly 
interesting as it is the most commonly mutated gene in congenital heart disease (Schott et 
al. 1998). Recently, it has been shown that the expression of Nkx2-5 is significantly 
increased in patients with hypertrophic cardiomyopathy. (Kontaraki et al. 2007). 
Nkx2-5 
The earliest known marker of cardiogenesis in vertebrates is Nkx2-5, also known as CSX 
(Tonissen et al. 1994; Harvey 1996). Nkx2-5 is a homeodomain transcription factor that 
starts being expressed during gastrulation and continues to be expressed throughout 
adulthood. In vertebrates, the expression of Nkx2-5 starts in presumptive cardiac cells 
and continues to be restricted to the adult heart. Nkx2-5 is a member of the NK2 family 
of homeodomain transcription factors. It is a DNA binding protein that acts as a dimer 
with itself or another family member (Kasahara et al. 2001). Nkx2-5 has two DNA 
binding domains: a homeodomain that binds the sequence TYAAGTG and an Nk2 
domain that binds the sequence CWTAATTG (Chen et al. 1995). In some known targets, 
such as the gene atrial natriuretic factor (ANF), the two binding sites are in close 
proximity in what is known as an Nk2 enhanced element (NKE) (Small et al. 2003). 
            2
 A common name for Nkx2-5 is tinman, due to its orthology to the Drosophila 
melanogaster gene tinman (Tonissen et al. 1994; Evans et al. 1995). In Drosophila 
melanogaster, tinman is required for the formation of the insect equivalent of the heart – 
the dorsal vessel (Bodmer 1993). Tinman is named after the character in Baum’s The 
Wonderful Wizard of Oz, because when the gene is knocked out, the organism lacks a 
heart, like the Tin Man in the story (Bodmer 1993). Drosophila tinman directly regulates 
other cardiac related factors, such as myocyte enhancer factor-2 (Mef2) (Gajewski et al. 
1998). 
In vertebrates, the role of Nkx2-5 isn’t so clear. At least ten Nkx2 family members have 
been identified across many vertebrate species. In Xenopus laevis, Nkx2-3, Nkx2-5, and 
Nkx2-10 are all expressed in the heart field (Sparrow et al. 2000). Overexpression of 
Nkx2-5 in Xenopus laevis causes a large-heart phenotype (Cleaver et al. 1996; Harvey 
1996). However, knocking down Nkx2-5 in Xenopus laevis or Danio rerio using a gene-
specific morpholino oligonucleotide causes cardia bifida, but no loss of the heart organ, 
in contrast to Drosophila (Nagao et al. 2008; Tu et al. 2009). This is thought to be due to 
functional redundancy between the various family members (Fu et al. 1998; Grow et al. 
1998). In order to test this, a dominant negative mutant was developed: Nkx2-5LP (Grow 
et al. 1998) (Figure 1.1). Nkx2-5LP does not effectively bind DNA, rendering it 
incapable of directing cardiogenic transcription. Furthermore, because Nkx2-5 operates 
as a heterodimer, the functional redundancy afforded by other family members was also 
blocked.
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 A 
 
B 
 
Figure 1.1 – Location of amino-acid change in the homeodomain of Nkx2-5LP 
dominant negative 
A) Drosophila melanogaster vnd/NK-2 homeodomain protein bound to DNA (PDB: 
1NK3) (Gruschus et al. 1997) (rendered using pymol) (DeLano Scientific 2009). B) 
Location of leucine to proline substitution in Nkx2-5LP is shown in red. In Nkx2-5, this 
substitution results in the total loss of cardiac tissue (Grow et al. 1998).
            4
 In Mus musculus, Nkx2-5 isn’t required for cardiac specification, as it is in Xenopus 
laevis. Nkx2-5 knockouts are embryonic lethal at day 9.5-11.5 in the mouse – not 
because of the lack of cardiac tissue, but rather due to improper looping of the heart tube 
(Lyons et al. 1995). However, in murine P19 carcinoma stem cells, over-expression of 
Nkx2-5 is enough to drive the cells to differentiate into the cardiac lineage (Jamali et al. 
2001). 
Nkx2-5 is auto-regulatory, meaning that it can regulate its own expression though a 
positive feedback loop (Oka et al. 1997). Nkx2-5 is also known to directly interact with a 
number of other gene products, including GATA4 (Durocher et al. 1997; Riazi et al. 
2009) and Tbx5 (Bruneau et al. 2001; Hiroi et al. 2001) to regulate the transcription of 
genes specific to cardiomyocytes (Figure 1.2). Examples of these targets are "-cardiac 
actin, ANF and myosin light chain 2 (MLC2) (Sepulveda et al. 1998; Tanaka et al. 1999). 
Many of these targets are expressed only in terminally differentiated, adult, 
cardiomyocytes. One of the known targets of Nkx2-5 in earlier development is 
myocardin (Myocd), which is required for cardiomyogenesis (Ueyama et al. 2003). In 
Xenopus laevis, myocardin doesn’t start to be expressed until stage 24, well after the start 
of Nkx2-5 expression (Small et al. 2005). The lack of knowledge about early stage targets 
means that the role(s) of Nkx2-5 in early development have still not been fully explored.
            5
 Other cardiogenic factors 
Initial cardiogenesis patterning seems to occur in response to positive and negative 
morphogen gradients such as the members of the bone morphogenic protein (BMP) 
family, Wnt, and Wnt antagonists (Harvey et al. 2002). In addition to Nkx2-5, there are 
many other genes that have a role in early cardiomyocyte determination (Figure 1.2).  
The TGF-! signaling pathway is one such contributor. The TGF-! signaling cascade 
starts with BMP4 and ultimately results in activation of SMAD1 and SMAD4 (Brown et 
al. 2004). SMAD4 can then interact with GATA4 to regulate Nkx2-5 expression and 
drive cardiogenesis (Brown et al. 2004). The role of TGF-! is further supported by 
experiments demonstrating that a constitutively active TGF-! receptor can result in the 
upregulation of cardiogenic factors (Brown et al. 2004). Like BMP4, treatment with 
activin can also initiate cardiomyocyte differentiation via TGF-! signaling (Ariizumi et 
al. 2003). 
The GATA family members are also important in early cardiogenic determination. 
GATA family members are zinc-finger transcription factors that bind to the rough 
consensus sequence [AT]GATA[AG] (Molkentin et al. 2000) and all are expressed in the 
presumptive heart field, and exhibit an overlapping expression pattern, suggesting 
functional redundancy (Peterkin et al. 2005). The idea of functional redundancy is 
reinforced by experiments involving GATA4 deficient mice where heart development 
continued, apparently compensated for by an increase in GATA6 expression (Pikkarainen 
et al. 2004). GATA6 has also been shown to activate BMP4 in adjacent endoderm, which 
might be required for maintenance of Nkx2-5 expression (Peterkin et al. 2003). Nkx2-5 is  
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 known to cooperate with GATA members in activating cardiac gene expression 
(Durocher et al. 1997). Nkx2-5 and GATA4 have also been shown to mutually regulate 
each other in a positive feedback loop (Schwartz et al. 1999). 
Another important pathway for cardiogenesis is Wnt signaling. Wnt signaling can be 
separated into two main classifications: canonical and non!canonical. Canonical Wnt 
signaling involves the interaction of secreted Wnt factors with the receptor Frizzled that 
activates "!catenin signaling. "!catenin signaling blocks cardiogenesis (Schneider et al. 
2001). Additionally, treatment with the Wnt antagonists Dickkopf!1 or Crescent directly 
inhibits Wnt/"!catenin signaling. This inhibition then caused enhanced cardiomyocyte 
differentiation (Schneider et al. 2001; Pandur et al. 2002; Latinki# et al. 2003). This is in 
direct contrast to non!canonical Wnt signaling with Wnt-11. Wnt!11 does not activate 
"!catenin but instead activates PKC/JNK which also enhances cardiomyocyte 
differentiation (Pandur et al. 2002).  
Induction of stem cells to cardiomyocytes 
In addition to studying cardiogenesis in developing embryos, there are two cardiogenic 
stem cell induction models that should be mentioned. In these models, pluripotent stem 
cells are induced to form cardiomyocytes by exposure to an external factor. The most 
common induction model is the murine P19CL6 carcinoma cell line (McBurney et al. 
1982; Habara-Ohkubo 1996). P19CL6 cells are derived from embryonal carcinoma cells 
and have the ability to differentiate into cardiomyocytes after exposure to 1% dimethyl 
sulfoxide (DMSO). After a 10-day incubation in the presence of DMSO, P19CL6 cells 
start to exhibit spontaneous contractions (Figure 1.2) (Habara-Ohkubo 1996). DMSO 
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 induction requires BMP signaling via TGF "-activated kinase 1 (TAK1); however, the 
exact mechanism remains unknown (Monzen et al. 1999). Treatment of P19 cells with 
the DNA methyl transferase inhibitor 5-azacytidine has also been shown to induce 
cardiac differentiation (Choi et al. 2004). While the exact mechanism of 5- azacytidine is 
unknown, it may be an indirect effect related to altered TGF-" signaling in response to 5-
azacytidine (Zuscik et al. 2004). 
The other stem cell model for cardiomyocyte induction commonly used is animal cap 
explants from Xenopus laevis. Animal caps are the section of an embryo consisting of 
tissue from the animal pole above the blastocoel cavity. Animal caps can be extracted 
around stage 8-9. Because they are not exposed to the inductive signals from the vegetal 
region, they are left in a naïve state. If animal caps are cultured with recombinant human 
activin (Ariizumi et al. 2003) or injected with GATA4 mRNA (Latinki# et al. 2003), they 
can form spontaneously beating structures. 
Use of Xenopus laevis in research 
The African clawed frog, Xenopus laevis, has been a popular model organism for 
developmental studies for many years. The fate of each cell has been mapped and 
developmental staging has been well established (Faber et al. 1994). However, the 
biggest advantage that Xenopus laevis offers is the large size of their embryos. Xenopus 
laevis females can be induced to lay eggs by the injection of human chorionic 
gonadotropin (hCG), which was an early method for pregnancy testing in humans 
(Polack 1949). Xenopus laevis eggs are large (~1mm), which allows for easy surgical 
manipulation and microinjection of synthetic mRNA. Directly injecting mRNA into the 
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 developing embryo allows a researcher to perturb a developmental gene network by over-
expressing a gene, introducing a dominant-negative, or knocking out a gene using small 
interfering RNA (siRNA) or morpholino oligomers (Heasman et al. 2000). 
This would suggest that Xenopus laevis would be heavily exploited in genomic studies, 
but this is not the case. Among 4 key model organisms that have between 10000 and 
17000 PubMed references since 2000, Xenopus laevis has by far the fewest expression 
datasets in the NCBI GEO database, by factors of 4 to 18-fold (Table 1.1). One possible 
reason for the lack of genomic studies is that Xenopus laevis is an allotetraploid, having 
an incomplete second copy of the genome (Hughes et al. 1993; Sive et al. 2000). Thus, 
there are potentially four copies of a gene, two of which may be degenerate. This has 
made the sequencing of the Xenopus laevis genome and further genetic analysis difficult. 
However, that hasn’t made the use of Xenopus laevis in genome-scale experiments any 
less desirable. Instead, other techniques were needed to compensate for the genetics of 
Xenopus laevis. Instead of relying on a fully sequenced genome to determine sequences 
of probes to measure gene expression, the transcriptome itself can be used. UniGene 
clusters from NCBI (Pontius et al. 2003; Wheeler et al. 2008) are a representation of all 
transcript sequences known for an organism. UniGene does not require a fully sequenced 
genome and is based on known mRNA sequences and unidentified EST sequences. In 
this way, UniGene can be used to determine probe sequences for use in microarray 
analysis (below).  
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 Table 1.1 – Summary of PubMed records and GEO datasets by organism 
Organism  PubMed 
records 
% of  
total 
PubMed  
GEO 
datasets 
% of  
total 
GEO  
GEO/PubMed 
ratio 
Mus musculus 485,384 50.8% 97,993 63.6% 0.20 
Rattus norvegicus 390,706 40.9% 32,046 20.8% 0.08 
Gallus gallus 26,513 2.8% 2,984 1.9% 0.11 
Drosophila melanogaster 17,411 1.8% 13,014 8.5% 0.75 
Caenorhabditis elegans 12,233 1.3% 4,362 2.8% 0.36 
Danio rerio 12,789 1.3% 2,744 1.8% 0.22 
Xenopus laevis 10,522 1.1% 714 0.5% 0.07 
Xenopus tropicalis 358 0.0% 110 0.1% 0.31 
Total 955,916  153,967   
Date retrieved: May 4, 2011 
Counts for PubMed records and GEO datasets were compiled by searching the NCBI 
PubMed and GEO databases. Queries were restricted to return results from only the given 
organism. The total numbers of records returned were taken as the record counts. 
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 In order to compensate for the lack of functional gene annotation in Xenopus laevis, 
another approach can be used. Cross-species annotation using gene homology is one 
promising technique. Gene ontology (GO) terms are the standard mechanism by which 
the functions of genes are described (Ashburner et al. 2000b). GO terms are classified 
into one of three hierarchies: molecular function, biological process, and cellular 
component. Using these three hierarchies, it is possible to completely describe the 
function, role, and localization of a protein. Because Xenopus laevis genes are largely 
unannotated, the function of many genes can not readily be found. Even for well-studied 
genes, the annotations for Xenopus laevis may be lacking in many databases. For 
example, it is well known that Nkx2-5 is involved in heart development; however, in the 
UniProt Gene Ontology Annotations (GOA) database (Camon et al. 2004b), Nkx2-5 is 
missing the GO annotation for heart development (GO: 0007507). Indeed, the only major 
organism that has Nkx2-5 correctly associated to heart development using non-
electronically inferred annotation is Mus musculus. In order to overcome this obstacle, 
annotations from a variety of organisms can to be assimilated to augment the existing 
annotation of Xenopus laevis genes. 
The lack of a fully sequenced genome makes certain types of analysis, such as promoter 
analysis, impossible in Xenopus laevis. While the full genome sequence of Xenopus 
laevis is not available, the sequence of its close diploid cousin, Xenopus tropicalis, is 
available (Hellsten et al. 2010). The two organisms are so closely related that RNA from 
one organism can be readily hybridized to a cDNA library from another (Figure 1.3). 
Because of the close similarity between Xenopus laevis and Xenopus tropicalis, Xenopus 
laevis transcripts can be mapped to the Xenopus tropicalis genome. By treating the 
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 Xenopus tropicalis genome as a surrogate for the Xenopus laevis genome, sequence-level 
analysis can be pursued. 
Microarray analysis of gene expression 
Microarray analysis of gene expression is the parallelization of the traditional northern 
blots. Northern blotting can detect the abundance of a particular RNA in a sample, using 
DNA or RNA probes complimentary to the target RNA molecule (Alwine et al. 1977). In 
northern blotting, the total RNA sample containing the target RNA is separated using 
electrophoresis and attached to a nitrocellulose membrane by blotting. The probes are 
synthesized with a detectable label, such as radioactive 32P. The probes are then 
hybridized to the membrane and the abundance of the target RNA in the sample is then 
measured using autoradiography or a similar technique.  
Microarray analysis is the inverse of this technique. With microarray analysis, probes 
targeting many genes are immobilized on a substrate in a known array pattern, allowing 
the detection of many genes in parallel. Once extracted from the sample of interest, the 
target is labeled with a detectable moiety, such as a fluorescent dye or biotin molecule. 
Labeled targets are hybridized to the array and measured using digital imaging (Schena et 
al. 1995).  
Microarrays enable genome-scale gene expression experiments due to the sheer number 
of probes that can be present on an array. Today, a typical array can contain up to a 
hundred thousand probes, potentially covering all known genes for an organism. When 
multiple samples are compared, global changes in gene expression can be measured and 
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Figure 1.3 – Hybridization of Xenopus tropicalis heart RNA to a Xenopus laevis 
spotted cDNA microarray 
This spotted microarray contains cDNA from a Xenopus laevis cDNA heart library and 
was fabricated at the Center for Medical Genomics at Indiana University School of 
Medicine using a VersArray ChipWriter Pro microarray robot (Bio-Rad, Hercules, CA). 
RNA was extracted from the pooled hearts from Xenopus tropicalis frogs, labeled with 
Cy3 dye, and hybridized to the microarray. This was then scanned using an Axon 
GenePix Scanner (Molecular Devices, Sunnyvale, CA). The presence of signal across a 
variety of probes shows that Xenopus tropicalis and Xenopus laevis have very similar 
gene sequences.
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 analyzed. One can measure gene expression in different tissues, differing stages of the 
cell cycle, drug dose response, or changes resulting from gene perturbation (knock-out or 
overexpression). 
Affymetrix GeneChip arrays are a specific type of microarray in which probes are 
directly synthesized onto silicon wafers, using the same photolithographic techniques that 
are used in the semiconductor industry (Fodor et al. 1991; Lipshutz et al. 1999). In this 
technique, multiple probes are used in concert to detect the abundance of a single gene. 
By using multiple probes, closely related genes and splice variants can be measured 
independently. The group of multiple probes used to measure the abundance of a single 
target transcript is called a probe set. 
One kind of GeneChip produced by Affymetrix is the Xenopus laevis Genome Array. 
This chip contains 15,503 probesets covering approximately 14,400 unique Xenopus 
laevis transcripts1. Transcript sequences for this GeneChip were based upon NCBI 
UniGene build 36 for Xenopus laevis (June 2003) (Pontius et al. 2003; Wheeler et al. 
2008). Selection of the gene targets included on the chip was based upon annotated genes 
and input from the Xenopus laevis research community at large. 
Gene Ontology  
The Gene Ontology project provides a common vocabulary to describe the characteristics 
of genes and their functions (Ashburner et al. 2000b). The vocabulary is provided as a 
hierarchy of terms in parent-child relationships. These are commonly referred to as GO 
                                                
1 http://media.affymetrix.com/support/technical/datasheets/xenopus_datasheet.pdf 
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 terms. Three different hierarchies are available: molecular function, biological process, 
and cellular component. The hierarchies are very flexible, allowing a term to have more 
than one parent term. With a controlled vocabulary, functional annotations are not limited 
by organism classification. With this vocabulary it is possible to extend annotations 
across homologous genes and proteins, even across species, in a manner that allows the 
accurate description of shared biology. 
Individual genes can be annotated with GO terms, representing their particular molecular 
function, cellular location, or involvement in any biological processes. GO annotations 
can be derived from published experiments, manual curation, or inferred from homology 
to another annotated gene. Each annotation has an associated evidence code, which 
details the type of experimental evidence that yielded the annotation. 
Scope of this work 
This work has one main goal: the identification of potential targets of Nkx2-5 in early 
development (Chapter 2). A method for further exploring identified targets is then 
applied to selected targets (Chapter 3). By using Xenopus laevis embryos for the initial 
target identification, some unique data analysis challenges had to be overcome. A 
database was created to help overcome these challenges (Chapter 4). 
Identifying targets of Nkx2-5 is important to help reveal the early signaling pathways that 
are critical for cardiogenesis. Chapter 2 describes one technique for studying early targets 
of Nkx2-5: the analysis of changes in global gene expression caused by over-expression 
of Nkx2-5 in whole Xenopus laevis embryos. Synthetic Nkx2-5 mRNA was injected into 
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 8-cell embryos in regions from which cardiomyocytes are derived. Once the embryos 
reached stage 11.5, total RNA was harvested from the embryos. Stage 11.5 was chosen 
because it is just after endogenous Nkx2-5 starts to be expressed around stage 10, so if 
any other co-factors are required for binding, they should also be present. Because initial 
Nkx2-5 is restricted to a small subset of cells in the embryo, it was impossible to attempt 
to dissect out only the presumptive cardiac field. Thus, the whole embryo needed to be 
used for gene expression analysis. Changes in global gene expression were measured by 
comparing the abundance of transcripts using the Affymetrix Xenopus laevis Genome 
Array GeneChip in Nkx2-5 injected embryos and in others injected with GFP (as a 
control). By incorporating annotations derived from other organisms (Chapter 4), 
examination of gene networks and GO enrichment is possible. The end result of the 
microarray analysis, coupled with cross-species annotations, is a list of potential targets 
of Nkx2-5. 
One method for implicating other genes is profiling their expression patterns among 
different developmental stages. The expression patterns for many genes can then be 
correlated to show how similar they are. This presents indirect evidence that genes may 
be co-regulated, but it doesn’t provide direct evidence of causality. In Chapter 3, several 
potential targets identified in Chapter 2 are profiled using semi-quantitative RT-PCR and 
a subset of those were further profiled using quantitative real-time PCR. Their expression 
patterns were then correlated with the expression pattern of Nkx2-5. 
In order to overcome some of the difficulties inherent to genomic studies in Xenopus 
laevis, a database of cross-species annotations was required. Chapter 4 describes the 
creation and uses of such a database. While the database itself isn’t specific to Xenopus 
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 laevis, it is one of the few databases of gene orthology to include Xenopus laevis as a 
supported organism. The database was constructed by finding orthologous clusters of 
genes from 8 eukaryotes: Homo sapiens, Mus musculus, Rattus norvegicus, Gallus 
gallus, Xenopus laevis, Danio rerio, Drosophila melanogaster, and Caenorhabditis 
elegans. Gene sequences were based on NCBI UniGene clusters for each organism 
(Pontius et al. 2003; Wheeler et al. 2008). These are found by clustering sequenced 
mRNAs and expressed sequence tags (ESTs) to form consensus gene sequences. GO 
annotations for each gene were then obtained from the EBI Gene Ontology Annotation 
(GOA) database (Camon et al. 2004b). Using the constructed network of orthologous 
genes, annotations from each member of the network can then be applied to the network 
as a whole.  
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 CHAPTER 2: IDENTIFICATION OF PUTATIVE TARGETS OF NKX2-5 IN 
XENOPUS LAEVIS 
Introduction 
The heart is the first organ to form in the developing embryo. Nkx2-5 is a cardiogenic 
homeodomain transcription factor that is required for proper vertebrate heart 
development; it is the earliest known marker of the presumptive heart field (Grow et al. 
1998; Schwartz et al. 1999). The binding sites of murine Nkx2-5 has been characterized 
by Chen and Schwartz and been shown to have two distinct binding sites: an NK2 
domain and a homeodomain binding site(Chen et al. 1995). Many targets of Nkx2-5, such 
as ANF, myocardin, and cardiac $-actin have also been found in both late stage embryos 
and adults (Akazawa et al. 2005). While expression of Nkx2-5 has been well 
characterized at later stages, and cofactors such as GATA4 (Bruneau 2002) and Tbx5 
(Durocher et al. 1998; Riazi et al. 2009) have been discovered, the role of Nkx2-5 
expression very early in development remains uncertain. To find novel targets of Nkx2-5 
in the early stages of development, we turned to whole embryo gene expression analysis 
in Xenopus laevis. 
Over the past decade, gene expression analysis has proven to be an invaluable tool in 
deciphering molecular function. However, the scale of the experiments makes data 
analysis a rate limiting factor. A key aspect is ensuring the proper annotation of the 
genes. Unfortunately, the quality of annotations varies heavily from organism to 
organism. Even though Xenopus laevis is a well-studied organism, annotation of its 
genome is limited. As discussed in Chapter 1, a primary reason for the lack of quality 
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 annotation is that Xenopus laevis is an allotetraploid, which has made traditional genetic 
studies using Xenopus laevis difficult (Sive et al. 2000). For example, in order to 
successfully target a gene for knock down studies, one needs to consider two (possibly 
degenerate) copies of the gene. We sought to compensate for the lack of annotation in 
Xenopus laevis by incorporating functional annotation from other organisms using the 
CrossGene database (Chapter 4). CrossGene forms clusters of similar genes using 
reciprocal best BLAST hits and pools GO annotations from all members of the cluster. 
While the genome of Xenopus laevis remains unsequenced, a reference assembly of the 
close cousin, Xenopus tropicalis, is available (Hellsten et al. 2010). Because of the 
similarity between Xenopus laevis and Xenopus tropicalis, Xenopus laevis transcripts can 
readily be mapped to the Xenopus tropicalis genome. Using the Xenopus tropicalis 
genome as a surrogate for the Xenopus laevis genome, sequence-level analysis is also 
possible. By exploiting gene annotations from other organisms and genomic sequence 
from Xenopus tropicalis, we can augment existing Xenopus laevis annotations to help 
drive data analysis. 
To find potential targets of Nkx2-5 in the early stages of heart specification, Xenopus 
laevis embryos were injected with synthetic Nkx2-5 mRNA and changes in gene 
expression were measured using Affymetrix GeneChip microarrays. Using cross-species 
orthologs and annotation, we found broad changes in GO term enrichment and pathways 
consistent with the developmental role of Nkx2-5. Using this information and sequence-
based analysis of potential Nkx2-5 binding sites, a list of likely Nkx2-5 targets was 
compiled. The resulting pathway analysis suggests a greater role for Nkx2-5 in the 
            20
 regulation of early development and provides researchers with a list of potential Nkx2-5 
targets. 
Methods 
Plasmid constructs 
Plasmids for microinjection were previously created by cloning the coding region of the 
Nkx2-5 gene into the pT7Ts expression vector (Grow and Krieg, 1998). pT7Ts contains 
inserts from the 5’ and 3’ untranslated regions (UTR) from the Xenopus laevis "-globin 
gene which aids with mRNA stability and translation in vivo. Inserts into this plasmid can 
be easily transcribed into RNA in vitro using a T7 RNA polymerase. In microarray 
analysis, the lack of the Nkx2-5 3’ UTR makes it possible to differentiate between 
endogenous Nkx2-5 mRNA and the injected mRNA. In addition to Nkx2-5, an additional 
construct was used, which includes an HA epitope tag at the 5’ end of the Nkx2-5 gene 
(Nkx2-5HA) (Figure 2.1). The addition of this tag makes it possible to differentiate 
between endogenous Nkx2-5 RNA and injected synthetic Nkx2-5 RNA. 
GFP was also previously cloned into the pCS2+ expression plasmid. This plasmid is 
similar to the pT7Ts plasmid, in that inserts can be in vitro transcribed to RNA, but in 
this case, SP6 RNA polymerase is used. Also, pCS2+ does not contain the extra 5’ and 3’ 
UTR inserts for Xenopus laevis "-globin.
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 Figure 2.1 – Plasmid map of Nkx2-5HA 
Nkx2-5HA is a plasmid based on the pT7Ts expression vector. It includes the coding 
region of Nkx2-5 as well as an in-frame HA epitope. Incorporating "-globin 5’ and 3’ 
UTRs helps to maintain stability when transcribed to RNA.
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 Generation of synthetic mRNA for microinjection 
Synthetic mRNA was generated from the Nkx2-5HA-pT7Ts and GFP-pCS2+ plasmids 
using an mMessage mMachine high-yield capped RNA transcription kit (Ambion, 
Austin, TX), containing the appropriate RNA polymerase enzyme, T7 and SP6 
respectively. Prior to mRNA synthesis, each plasmid was linearized by digesting the 
plasmid with the appropriate restriction enzyme. Nkx2-5HA-pT7Ts was linearized using 
EcoRI (Promega, Madison, WI) and GFP-pCS2+ was linearized using NotI (Promega). 
The digestion reaction was terminated by ethanol precipitation. RNA transcription was 
then performed according to the manufacturer’s instructions resulting in capped, 
synthetic mRNAs. Synthesized mRNA was then purified using the MEGAclear 
purification kit (Ambion). RNA quality and yield were assessed by UV/Vis 
spectrophotometry using a NanoDrop spectrophotometer (Ambion) and agarose gel 
electrophoresis. 
Culturing of Xenopus laevis embryos 
Xenopus laevis embryos were collected, cultured, and manipulated using the techniques 
and protocols described by Sive, et al. (Sive et al. 2000). Xenopus laevis eggs were 
harvested by injecting a female frog with 400U of human chorionic gonadotropin the 
night before embryos were required. The following morning, eggs were harvested by 
inducing the female to lay eggs by physical manipulation. The eggs were collected in 
Petri dish and a solution of 0.1X Mark’s modified Ringer’s solution (MMR), pH 7.5 was 
added. Eggs were fertilized in vitro by mincing a small piece of freshly dissected testes in 
the dish. Fertilization was confirmed when the animal pole of the embryo has turned to 
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 face the top of the dish. The protective jelly coating on the embryos was removed by 
rinsing the embryos in a solution of 3% cysteine until the jelly coating was sufficiently 
removed. Embryos were then washed multiple times in 0.1X MMR. 
Embryos destined for microinjection were cultured until they reached the 4-8 cells stage 
(Nieuwkoop and Faber). Other embryos were allowed to develop normally in 0.1X MMR 
at 18-25°C until they reached desired developmental stages. These embryos were either 
used directly for RNA extraction or were fixed in NOTOXhisto fixing agent (Scientific 
Device Laboratory, Des Plaines, IL) for 2 hours (Acton et al., 2005) and stored at 4°C in 
methanol. 
Microinjection of synthetic mRNA into Xenopus laevis embryos 
Prior to injection, embryos were transferred to a 3% solution of Ficoll 400/0.1X MMR. 
Embryos were injected with either 250pg GFP mRNA or 250pg GFP mRNA and 250pg 
Nkx2-5HA mRNA. The RNA was diluted in water to yield a total injection volume of 
4.6nl. GFP was used as a tracer so that it could later be determined where and if the 
injected RNA was actively being translated into protein. Each embryo was injected 
bilaterally in the dorsal vegetal blastomere with either the GFP only or GFP+Nkx2-5HA 
mRNA solutions using a Nanoject II (Drummond Scientific, Broomall, PA) (Figure 2.1). 
Embryos were cultured overnight at 15°C in the Ficoll solution. The following day, the 
Ficoll solution was replaced with 0.1X MMR and embryos were incubated until they 
reached stage 10. Then they were sorted to include only embryos that were positive for 
GFP expression in the cardiac crescent region (Figure 2.3).
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 Figure 2.2 – Location of synthetic mRNA injection 
An animal pole view of an 8-cell Xenopus laevis embryo, indicating the areas targeted for 
RNA injection (adapted from Faber and Nieuwkoop, 1994).  
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 Figure 2.3 – Sorted embryos showing GFP expression in the cardiac crescent 
Embryos were sorted based upon their levels of GFP expression in the cardiac crescent, 
indicating that injected mRNA was present in the correct region.
            26
 Harvesting RNA from Xenopus laevis embryos 
RNA was extracted from individual embryos, pooled batches of stage-matched embryos, 
and adult tissue. Embryos that were fresh or directly stored in TRIzol reagent without 
further treatment were homogenized in TRIzol. Individual embryos and small pools (n<5) 
were homogenized using an autoclaved polypropylene microcentrifuge tube pestle (USA 
Scientific, Ocala, FL) prior to homogenization with an Ultra-Turrax T8 rotor/stator 
homogenizer (IKA Works, Wilmington, NC). Larger pools of embryos and tissues were 
homogenized only with the Ultra-Turrax T8 rotor/stator homogenizer. Chloroform phase 
extraction, followed by isopropanol precipitation was performed, following the 
manufacturer’s instructions, resulting in isolated total RNA. For low concentration 
samples, 1µl of GlycoBlue glycogen (Ambion) was used as a carrier for the RNA. 
Isolated RNA was then cleaned up using a size appropriate RNeasy purification kit 
(Qiagen, Valencia, CA). RNA quality and yield were determined by UV/Vis 
spectrophotometry. 
Reverse transcription PCR confirmation 
The presence or absence of Nkx2-5HA synthetic mRNA was confirmed using non-
quantitative reverse transcription PCR (RT-PCR). For each sample, 500ng of total RNA 
was reverse transcribed into cDNA using a SuperScript II Reverse Transcriptase kit 
(Invitrogen) in a 20µl reaction using anchored oligo-dT as a primer. These cDNAs were 
diluted to 100µl using water, resulting in solutions that contained the equivalent of 5ng/µl 
of the original RNA. Next, 1µl of the diluted cDNAs were amplified using a Platinum 
Taq DNA Polymerase High Fidelity PCR kit (Invitrogen) using primers specific for 
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 ornithine decarboxylase (ODC) and Nkx2-5HA. Primers were designed algorithmically 
using Primer3 software with the parameters listed in table A1.1 (Rozen et al. 2000). ODC 
was used as an internal control. Nkx2-5HA primers were designed to be specific to that 
construct and to not amplify endogenous Nkx2-5 (Figure 2.4). The PCR conditions were: 
94°C for 2 minutes; 30 cycles of 94°C for 30 seconds, 55°C for 30 seconds, and 68°C for 
2 minutes; followed by 72°C for 7 minutes. 
PCR products were visualized using agarose gel electrophoresis. The gel was stained 
with ethidium bromide (EtBr) and visualized on a 312nm UV light box. A picture was 
captured using a Nikon COOLPIX 995 digital camera equipped with an EtBr light filter 
(Nikon, Tokyo) and processed using Adobe Photoshop (Adobe, San Jose, CA). 
Head versus tail dissection 
Xenopus laevis embryos were cultured until they reached stage 18. Embryos were then 
bisected along the anterior-posterior axis into “head” and “tail” regions using an eyebrow 
knife (Figure 2.5)(Sive et al. 2000). RNA from three paired head and tail regions were 
extracted as previously described. Additionally, pools of 7 head and 7 tail samples were 
collected and RNA extracted. RNA expression levels from these samples were also 
measured using Affymetrix GeneChip microarrays.
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 Figure 2.4 – Nkx2-5HA primers do not amplify endogenous Nkx2-5 
St. 41 cDNA was used as a template for a PCR reaction with Nkx2-5HA and Nkx2-5-RT 
primers. After 40 cycles, using St. 41 cDNA as a template, Nkx2-5RT primers fully 
amplified endogenous Nkx2-5. A weak band is visible in the Nkx2-5HA lane, but this 
was likely a gel-loading artifact.   
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 Figure 2.5 – Head versus tail bisection 
The line shows the approximate location of the cut used to bisect head versus tail sections 
of stage 18 embryos. This is a lateral view of a stage 22 embryo and is only used for 
illustration (adapted from Faber and Nieuwkoop, 1994). The lower arrow points to the 
approximate area of Nkx2-5 expression at this stage.
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 Microarray analysis 
Six Xenopus laevis embryos were injected with synthetic GFP mRNA (control samples). 
An additional six embryos were injected with a mix of synthetic GFP and Nkx2-5HA 
mRNA (experimental samples). The embryos were allowed to develop until they reached 
stage 11.5. At this point, total RNA was collected as previously described and cleaned up 
using an RNeasy micro RNA purification kit (Qiagen). Samples were treated with DNase 
(Qiagen) “on-column” to remove any traces of genomic DNA contamination that may 
have been present. RNA quality was determined using both UV/Vis spectrophotometry 
and a Bioanalyzer (Agilent Technologies, Santa Clara, CA). 400ng of each RNA sample 
were given to the Center for Medical Genomics at the Indiana University School of 
Medicine for processing and analysis using Affymetrix GeneChip microarrays.  
Using the standard Affymetrix two-cycle amplification protocol from 2006, 100ng of 
each RNA sample was amplified, biotinylated, and hybridized to a Xenopus laevis 
genome array GeneChip for 17 hours at 45°C. Affymetrix Microarray Suite 5.0 was used 
to generate and export expression data in the form of a raw signal value, a present/absent 
detection call, and a p-value related to the detection call. Once exported, data were 
analyzed using custom scripts written in Python with NumPy (Ascher et al. 1999; 
Oliphant 2006) and R (Team 2010).  
Using the BLASTN algorithm (Altschul et al. 1990a; Altschul et al. 1997b), the sequence 
of synthetic Nkx2-5HA mRNA was compared to the target sequences present on the 
Xenopus laevis genome GeneChip. No matches were found. However, the pT7Ts plasmid 
contains the 3’UTR sequence from Xenopus laevis "-globin, which caused the measured 
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 expression level of one "-globin probeset to be artificially inflated. The synthetic GFP 
mRNA did not have this issue. This probeset was ignored in further analysis.  
Statistical data analysis 
For each probeset, mean signal values were log-transformed and a Welch’s t-test 
performed (Welch 1947). Welch’s t-test differs from Student’s t-test in that it allows for 
unequal variances between the populations. Probesets were assigned to a Xenopus laevis 
UniGene cluster by comparing the target sequences for the probeset to the unique 
sequences for all Xenopus laevis UniGene clusters (Build 86) using the BLASTN 
algorithm (Altschul et al. 1990a; Altschul et al. 1997a). In all instances, the best overall 
match by e-value and score was used. Next, an absent/present (AP) filter was used to 
exclude probesets that were not marked present in 50% of either control or experimental 
samples (McClintick et al. 2003; McClintick et al. 2006). Probesets that did not match a 
Xenopus laevis UniGene cluster or had an e-value greater than 1e-50 were excluded. 
Individual probesets were considered separately even if they mapped to the same 
Xenopus laevis UniGene cluster. Next, the false discovery rate (FDR) q-value was 
calculated (Storey 2003). Probesets with an FDR q-value greater than 0.1, or with an 
absolute fold change less than 1.5 were excluded. Fold change was used as a filter to help 
ensure that any changes detected could be experimentally validated. Fold change was 
calculated by taking the ratio of the mean signal value from the Nkx2-5HA injected 
samples and the control GFP injected samples, with the larger of the two values used as 
the numerator. If the mean value of the control samples was the larger number, the value 
was shown as negative. 
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 Gene ontology enrichment and annotation 
Gene ontology annotations were retrieved from the CrossGene database (Chapter 4, Build 
0904) for the CrossGene reciprocal best-match group corresponding to the assigned 
Xenopus laevis UniGene cluster ID. For each term, the complete hierarchy of parent 
terms was also retrieved and added to the list in a non-redundant manner. The complete 
hierarchy of terms was used for classification of genes and enrichment analysis. 
Enrichment or depletion of a term was calculated based upon the deviation from the 
expected number of genes in a group annotated with that GO term. All 13,242 probesets 
that had a valid Xenopus UniGene match with an e-value less than 1e-50 were used as the 
reference. Probesets that passed the 1.5 fold change filter were split into over-expressed 
or under-expressed groups. Terms were split into groups based upon which GO 
namespace they belong to: molecular function, biological process, or cellular component. 
This resulted in 6 individual groupings of enrichment/depletion calculations. In each 
group, p-values were calculated for each term using Fisher’s exact test in R (Fisher 1970; 
Team 2010). The expected number of annotated genes was calculated based upon the 
percentage of genes in the reference set that were annotated with that term. Terms with an 
expected count of 1 were removed. 
Network / pathway analysis  
For each Xenopus laevis probeset, the Mus. musculus ortholog was determined by finding 
all Mus musculus genes present in the CrossGene reciprocal best-match group for the 
corresponding Xenopus laevis UniGene cluster. Mus musculus genes with corresponding 
Xenopus laevis fold change data were then loaded into Ingenuity Pathways Analysis 
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 (Ingenuity Systems) and networks algorithmically calculated. In cases where multiple 
Xenopus laevis probesets mapped to the same Mus musculus UniGene cluster, the 
average of the fold changes was used. Top differentially represented biological functions 
were determined using a Fisher’s exact test. Selected canonical pathways and interactions 
associated with Nkx2-5 were retrieved from Ingenuity’s Knowledge Base and fold 
change values were overlaid. 
Nkx2-5 binding site search 
Murine Nkx2-5 has two binding sites: an NK2 site (TYAAGTG) and a homeobox 
(HBOX) site (CWTAATTG) (Transfac: M00240, M00241)(Chen et al. 1995). Using the 
promoter of the known Xenopus laevis Nkx2-5 target gene ANF, as a guide, the mouse 
sequences were truncated to BAAGTG and WKAAT for searching in Xenopus (Small et 
al. 2003). Xenopus laevis UniGene unique sequences were mapped to Xenopus tropicalis 
predicted transcripts (Assembly 4.1) using BLASTN. The single best blast hit with the 
lowest e-value was treated as the corresponding Xenopus laevis gene. Next, the 2 kb 
region upstream of the Xenopus tropicalis transcript was retrieved and searched for NK2 
and HBOX potential binding sites of Nkx2-5. If two matches were within 20 bases of 
each other, they were treated as “paired” sites. 
Results 
Nkx2-5 overexpression 
In order to find potential targets of Nkx2-5, 8-cell Xenopus laevis embryos were 
bilaterally injected with synthetic mRNA for Nkx2-5 with GFP mRNA as a tracer (Figure 
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 2.6). Total RNA was extracted from whole stage 11.5 embryos that showed tracer GFP 
expression in the cardiac crescent region. Six Nkx2-5/GFP and six GFP-only embryos 
were used. RNA expression levels were measured using Xenopus laevis genome 
GeneChip microarrays (Affymetrix, Santa Clara, CA) (Figure 2.7, Figure 2.8). Results 
from these were then filtered based upon the Affymetrix absent/present call with a cutoff 
of 0.5 (McClintick et al. 2006). The false discovery rate (FDR) was then calculated and 
filtered using a cutoff of 0.1 (Storey 2003). Finally, we focused on probesets with 
changes exceeding ± 1.5 fold, resulting in a list of in 738 differentially expressed 
probesets covering 710 unique Xenopus laevis UniGene clusters (Table 2.1). Genes that 
were enriched in the Nkx2-5 overexpressed samples were considered up-regulated. 
Development and transcription related genes enriched 
To allow GO enrichment analysis of the 710 differentially expressed UniGene clusters, 
the Xenopus UniGene clusters represented on the GeneChip first needed to be annotated. 
Cross-species GO annotations were derived from the CrossGene database (Chapter 4) 
using best-match reciprocal groups. Enrichment of the 710 differentially expressed 
UniGene clusters was then calculated for biological process, molecular function and 
cellular location hierarchies using Fisher’s exact test (Appendix 2) (Fisher 1970).  
Analysis of up-regulated genes demonstrated that the top 10 molecular function terms 
were related mainly to DNA binding or transcription factor activity (Table 2.2), and in all 
10 categories the up-regulated genes were over-represented, providing evidence for the 
role of Nkx2-5 as a positive regulator of other transcription factors. Similarly, all of the 
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 Figure 2.6 – RT-PCR confirmation of the presence of injected Nkx2-5HA RNA 
Each lane represents total RNA isolated from a single embryo that was hybridized to a 
GeneChip. Synthetic GFP RNA was injected into all samples. Synthetic Nkx2-5HA RNA 
was injected into the last six samples. PCR primers specific to exogenous Nkx2-5HA 
were used to confirm the presence of Nkx2-5HA RNA. ODC was used as an internal 
control.
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 Table 2.1 – Microarray filtering for Nkx2-5 overexpression and head vs. tail  
Nkx2-5 overexpression 
Filter Cut off Matching probesets Unique UniGene 
All probesets (incl controls) 15,503  
Absent/Present Filter (!0.5) 11,408  
Xenopus laevis UniGene 86 match (e-value " 10-50) 9,818 8,845 
FDR filter ("0.1) 3,144 2,989 
Fold change (minimum) (±1.5X) 738 709 
     Up-regulated (+1.5X) 406 400 
     Down-regulated (-1.5X) 332 323 
 
Head vs. tail 
Filter  Matching probesets  
All probesets  15,503  
Absent/Present Filter (!0.75 in head*) 8,539  
Head enriched (>2X) 263  
* In order for a probeset to be called as head-enriched, it needed to be called as 
“Present” in at least 3 out of 4 head samples.
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 top 20 biological process terms showed an excess of up-regulated genes; many of these 
terms relate to cell differentiation, organism patterning, organogenesis, and other 
developmental pathways (Table 2.3), emphasizing the role of Nkx2-5 in early 
development. 
In contrast, analysis of down-regulated genes showed that 6 of the top 10 molecular 
function terms had fewer genes than expected (Table 2.4), and all 10 top biological 
process terms were related to development or growth and all showed fewer genes than 
expected (Table 2.5). 
Developmental pathways activated 
To examine which pathways were affected by Nkx2-5 over-expression, network analysis 
was performed. Xenopus laevis isn’t supported by Ingenuity Pathways Analysis software 
(IPA; Ingenuity Systems, Redwood City, CA), so we mapped Xenopus laevis genes to 
Mus musculus orthologs using the CrossGene database, which finds the best-match 
reciprocal groups. For network analysis, a larger number of genes can be advantageous, 
so we applied an FDR cut off of 0.1 but did not filter the results by fold change, leaving 
3,144 Xenopus laevis probesets for analysis (Table 2.1). These mapped to 2,923 unique 
Mus musculus UniGene clusters. These mouse orthologs along with the measured fold 
changes of the Xenopus laevis probesets were submitted for network analysis using IPA.  
Two of the top generated networks consisted of genes with functions related to 
development, however, only Network 2 included Nkx2-5 itself, and it is linked to only 
two other genes (MEOX1 and APLNR) (Figure 2.9); NF!B is the predominant node. 
Network 4, while missing Nkx2-5, contains other key developmental transcription factors 
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 Table 2.2 – Molecular function enrichment in up-regulated genes 
GO Term Expected Actual p-value 
GO:0003700 transcription factor activity 17 33 1.6E-04 
GO:0043565 sequence-specific DNA binding 13 26 5.8E-04 
GO:0003705 RNA polymerase II transcription factor activity, enhancer binding 2 7 7.1E-04 
GO:0016563 transcription activator activity 11 21 2.1E-03 
GO:0030528 transcription regulator activity 28 43 2.3E-03 
GO:0003677 DNA binding 33 49 3.4E-03 
GO:0003702 RNA polymerase II transcription factor activity 7 15 3.5E-03 
GO:0046982 protein heterodimerization activity 6 13 4.3E-03 
GO:0005099 Ras GTPase activator activity 2 5 6.5E-03 
GO:0003723 RNA binding 16 6 9.4E-03 
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 Table 2.3 – Biological process enrichment in up-regulated genes 
GO Term Expected Actual p-value 
GO:0003002 regionalization 11 31 5.5E-08 
GO:0007389 pattern specification process 15 37 9.7E-08 
GO:0035282 segmentation 4 16 1.3E-07 
GO:0030154 cell differentiation 27 53 2.6E-07 
GO:0009952 anterior/posterior pattern formation 6 21 3.7E-07 
GO:0032501 multicellular organismal process 55 87 4.5E-07 
GO:0045893 positive regulation of transcription, DNA-dependent 13 31 8.5E-07 
GO:0010557 positive regulation of macromolecule biosynthetic process 16 36 9.1E-07 
GO:0051254 positive regulation of RNA metabolic process 13 31 9.4E-07 
GO:0009887 organ morphogenesis 15 35 1.2E-06 
GO:0001756 somitogenesis 3 12 1.6E-06 
GO:0048598 embryonic morphogenesis 13 30 2.5E-06 
GO:0045944 positive regulation of transcription from RNA polymerase II promoter 10 26 2.5E-06 
GO:0007275 multicellular organismal development 30 54 2.8E-06 
GO:0031328 positive regulation of cellular biosynthetic process 16 36 2.9E-06 
GO:0009891 positive regulation of biosynthetic process 17 36 3.1E-06 
GO:0048731 system development 19 39 4.0E-06 
GO:0009893 positive regulation of metabolic process 20 40 8.2E-06 
GO:0048646 anatomical structure formation involved in morphogenesis 13 30 8.8E-06 
GO:0010604 positive regulation of macromolecule metabolic process 19 39 9.4E-06 
            42
 Table 2.4 – Molecular function enrichment in down-regulated genes 
GO Term Expected Actual p-value 
GO:0030695 GTPase regulator activity 5 12 6.7E-04 
GO:0060589 nucleoside-triphosphatase regulator activity 5 12 1.0E-03 
GO:0005083 small GTPase regulator activity 3 9 2.8E-03 
GO:0005198 structural molecule activity 11 2 2.9E-03 
GO:0003723 RNA binding 14 5 9.5E-03 
GO:0019904 protein domain specific binding 7 1 1.5E-02 
GO:0008233 peptidase activity 9 2 1.8E-02 
GO:0005096 GTPase activator activity 3 6 2.3E-02 
GO:0004175 endopeptidase activity 6 1 3.1E-02 
GO:0016887 ATPase activity 6 1 3.1E-02 
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 Table 2.5 – Biological process enrichment in down-regulated genes 
GO Term Expected Actual p-value 
GO:0048518 positive regulation of biological process 56 31 2.6E-05 
GO:0040008 regulation of growth 33 14 9.5E-05 
GO:0009653 anatomical structure morphogenesis 38 18 1.0E-04 
GO:0045927 positive regulation of growth 28 11 1.3E-04 
GO:0040009 regulation of growth rate 25 9 2.2E-04 
GO:0040010 positive regulation of growth rate 25 9 2.2E-04 
GO:0002119 nematode larval development 26 10 2.8E-04 
GO:0008152 metabolic process 104 82 5.6E-04 
GO:0032502 developmental process 87 65 6.6E-04 
GO:0002164 larval development 26 11 6.8E-04 
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 such as Jun, Sox2 and members of the Fox family, all of which were up-regulated by 
overexpression of Nkx2-5 (Figure 2.10). All of the top 5 differentially represented 
physiological functions were developmental (Table 2.6). 
Canonical pathways and known interaction partners of Nkx2-5 were also extracted from 
IPA and gene expression levels overlaid as the color for each node. Two of these 
pathways specifically covered cardiogenesis: “Factors Promoting Cardiogenesis in 
Vertebrates” (Figure 2.11) and “Cardiomyocyte Differentiation via BMP Receptors” 
(Figure 2.12). In both of these networks, members of the BMP family were up-regulated. 
Out of the 69 elements known to interact with Nkx2-5, only 12 exhibited any change in 
expression (Figure 2.13). 
Prioritization of potential Nkx2-5 targets 
Classification by head/tail expression 
Expression of Nkx2-5 is restricted to pre-heart tissue, so early targets should also be 
present in the early heart regions. However, at these early stages of development, the pre-
heart fields are still migrating, making exact dissection impossible. However, the anterior 
half of an embryo contains the early internal organ regions, including all of the migrating 
pre-heart tissue. By looking for genes that are enriched in this region, it is possible to 
eliminate more widely expressed genes. For this, stage 18 Xenopus laevis embryos were 
bisected into “head” and “tail” sections (Figure 2.5) and RNA expression was then 
characterized using GeneChips (Figure 2.14). To classify a probeset as “head-enriched”, 
the probeset had to be called present in 3 out of 4 head samples and be enriched 2-fold in  
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 Figure 2.9 – Selected IPA Network: Embryonic Development, Tissue Development, 
Organismal Development  
Xenopus laevis UniGene clusters were mapped to their Mus musculus orthologs using 
CrossGene best-match reciprocal groups. All genes that met a FDR cutoff of less than 0.1 
were used for network generation using IPA. This is one of the networks that were 
generated. The color of the nodes represents the fold change of the gene, or an average 
where more than one Xenopus laevis UniGene cluster mapped to a Mus musculus 
UniGene cluster. Genes enriched in the Nkx2-5 overexpression samples are shown in red 
and those enriched in the GFP control samples are shown in green.   
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 Figure 2.10 – Selected IPA Network: Cellular Development, Nervous System 
Development and Function, Embryonic Development 
Xenopus laevis UniGene clusters were mapped to their Mus musculus orthologs using 
CrossGene best-match reciprocal groups. All genes that met a FDR cutoff of less than 0.1 
were used for network generation using IPA. This is one of the networks that were 
generated. The color of the nodes represents the fold change of the gene, or an average 
where more than one Xenopus laevis UniGene cluster mapped to a Mus musculus 
UniGene cluster. Genes enriched in the Nkx2-5 overexpression samples are shown in red 
and those enriched in the GFP control samples are shown in green.  
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 Table 2.6 – Differentially represented physiological pathways 
Pathway or function p-value range # molecules 
Embryonic Development 2.1E-15 - 2.3E-03 251 
Tissue Development 2.1E-15 - 2.1E-03 211 
Organismal Development 4.5E-14 – 2.0E-03 267 
Cardiovascular System Development and Function 4.1E-09 – 2.0E-03 124 
Organ Development 4.1E-09 - 1.2E-03 184 
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 Figure 2.11 – IPA Canonical pathway: Factors Promoting Cardiogenesis in 
Vertebrates 
Building upon the earlier Ingenuity generated pathways using Mus musculus orthologs to 
Xenopus laevis genes, canonical pathways associated with Nkx2-5 were chosen based 
upon how many members were differentially expressed. Nodes are colored based upon 
their fold change. Genes enriched in the Nkx2-5 overexpression samples are shown in red 
and those enriched in the GFP control samples are shown in green.  
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 Figure 2.12 – IPA Canonical pathway: Cardiomyocyte Differentiation via BMP 
Receptors 
Building upon the earlier Ingenuity generated pathways using Mus musculus orthologs to 
Xenopus laevis genes, canonical pathways associated with Nkx2-5 were chosen based 
upon how many members were differentially expressed. Nodes are colored based upon 
their fold change. Genes enriched in the Nkx2-5 overexpression samples are shown in red 
and those enriched in the GFP control samples are shown in green.
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 the head samples; 263 probesets were classified as “head-enriched” (Table 2.1), among 
which 24 were in the list of potential Nkx2-5 targets (Table 2.7). 
Heart and transcription-related classification 
Based on gene ontology annotations from the CrossGene database, probesets that were 
annotated with either GO:0007507 (heart development) or GO:0003015 (heart process) 
were classified as “heart related”. In the set of 710 potential targets, 17 were classified as 
heart related (Table 2.7). Probesets annotated with GO:0003700 (transcription factor 
activity) or GO:0045449 (regulation of transcription) were classified as “transcription 
related” yielding 79 potential targets (Table 2.7).  
A smaller prioritized list of potential targets was created based upon these three criteria: 
enriched expression in the head-region, heart-related GO annotation, and transcription-
related GO annotation. The union of these classifications yielded 99 unique UniGene 
clusters, representing the most likely potential targets of Nkx2-5 related to heart 
development (Figure 2.15). 
Presence of possible Nkx2-5 binding sites 
Nkx2-5 has two binding sites: an NK2 site and a homeobox (HBOX) site (Chen et al. 
1995). An additional method for prioritizing potential targets for future study is to look 
for Nkx2-5 binding sites in the promoters of those targets. As a substitute for the Xenopus 
laevis genome, the Xenopus tropicalis 4.1 assembly was used. Predicted promoter regions 
were searched for potential Nkx2-5 binding sites. Of the 99 prioritized targets, 90 
contained at least one HBOX site and 81 contained at least one NK2 site (Table 2.7).  
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 Figure 2.13 – Known Nkx2-5 interacting partners  
This shows a network of all the genes and molecules in Ingenuity’s Knowledge Base 
known to interact with Nkx2-5 (center). 12 out of 69 interacting partners showed 
differences in gene expression in response to Nkx2-5 overexpression in stage 11.5 
Xenopus embryos. Direct interactions are shown in solid lines and indirect interactions 
are shown in dashed lines. Genes that were up-regulated in Nkx2-5 injected samples are 
shown in red. Down-regulated genes are shown in green.
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Figure 2.15 – Venn diagram showing the number of genes matching each 
classification type 
Based upon the 709 differentially expressed genes, genes were further classified by 
assigning them to three overlapping groups: heart-related genes (17), transcription-related 
genes (79), and genes that were enriched in the head-region of the embryo (24). Three 
genes matched all three groups: Nkx2-5, Pax3, and Twist1.
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Nkx2-5 binds DNA as a dimer, so potential binding sites near another site are particularly 
interesting (Kasahara et al. 2001). Additionally, in the promoter region of the known 
Nk2-5 target, ANF, there is an NK2 site paired with an HBOX site, which forms an 
enhanced NK (NKE) binding site (Small et al. 2003). Because of this, paired binding 
sites within 20 bases of each other were tallied. 55 of the 99 potential UniGene targets 
contained a NK2 site near an HBOX site (NKE), and 9 contained an NK2 site near 
another NK2 site (Table 2.7). 12 of the 17 heart-related targets, 10 of the 24 head-
enriched targets, and 47 of the 55 transcription related targets had at least one NKE site. 
Discussion 
Nkx2-5 is an essential transcription factor in cardiogenesis, but overexpression of Nkx2-5 
in stage 11.5 embryos showed a broader effect than previously imagined. Injection of 
synthetic mRNA for Nkx2-5 in the 8-cell stage led to changes in expression of thousands 
of genes at stage 11.5 (Table 2.1). Analyses of the pathways and networks affected 
showed up-regulation of transcription-factor and DNA-binding activity and 
developmental pathways, including cardiogenesis. The GO enrichment results also 
suggest that developmental genes are primarily up-regulated by over-expression of Nkx2-
5. Using a combination of regional expression and transcription- or heart-related 
annotation, a list of 99 prioritized targets was compiled (Table 2.7). The expression 
changes could be due to direct or indirect effects; the presence of putative Nkx2-5 
binding sites in the promoters of many of the genes suggests direct effects on many of the 
genes.  
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Two of the more interesting potential targets are Twist1 and Pax3. In the CrossGene 
database, Twist1 and Pax3 were both annotated as heart and transcription related, and 
they were both enriched in the head regions. The only other gene to have this annotation 
pattern was Nkx2-5 itself, which is known to be auto-regulatory (Oka et al. 1997; Reecy 
et al. 1999); this finding serves as a positive control for our approach. The synthetic 
Nkx2-5 mRNA that was injected into the embryos had a different 3’ UTR from 
endogenous Nkx2-5. Because of this, the GeneChip probesets for Nkx2-5 did not detect 
the injected Nkx2-5HA mRNA. Instead, the an increase in the expression of endogenous 
Nkx2-5 was detected, confirming the auto-regulation of Nkx2-5. Twist1 and Pax3 both 
contain paired Nk2/HBOX binding sites. In Drosophila melanogaster, twist directly 
regulates the Nkx2-5 ortholog tinman (Bodmer 1993; Yin et al. 1997) and it has been 
shown by a loss-of-function study to have an effect on cardiac neural crest cells in mouse 
(Vincentz et al. 2008). In Xenopus laevis, it was reported that they could not directly 
regulate each other during early development, as their expression patterns did not overlap 
at the appropriate stages (Evans et al. 1995). However, at earlier stages of development, 
their expression patterns may overlap enough to allow some degree of regulation. In 
Xenopus laevis, the Pax3 neurula expression pattern seems to be restricted to the anterior 
neural fold and doesn’t appear to overlap with Nkx2-5 (Xenbase image: 20246)(Bowes et 
al. 2010). However, in mouse, Pax3 is essential for heart development and is required for 
cardiac neural crest migration (Conway et al. 1997a; Conway et al. 1997b). This suggests 
a potential for interactions later in development. 
These results are the first step in the process of uncovering the earliest role and targets of 
Nkx2-5 in the developing embryo. It also represents a strategy for analysis of future 
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genome scale experiments in Xenopus laevis. With the help of cross-species annotations 
using CrossGene, it was shown that the overexpression of Nkx2-5 had large effects on 
development and transcription related pathways. Finally, on the basis of the changes in 
gene expression, external annotations, gene expression data from a bisected embryo, and 
the surrogate Xenopus tropicalis genome, a list of potential targets was compiled. These 
potential targets can be tested to establish a direct connection with Nkx2-5.  
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CHAPTER 3: EXPRESSION PROFILING OF SELECTED TARGETS  
Introduction 
Expression profiling of a gene involves measuring the amount of a specific RNA 
molecule in a sample over various conditions. This establishes a pattern of expression for 
that gene. If two genes have similar expression patterns, this indicates that they could 
share common regulatory signals. If one of those genes is auto-regulatory, such as Nkx2-
5, it could mean that the shared regulation between two genes may be the auto-regulatory 
gene itself. In general, a gene that auto-regulates itself will increase in abundance until it 
reaches a steady-state level (Figure 3.1A). However, if expression of the gene is restricted 
to a subset of cells and this subset of cells makes up a decreasing percentage of the 
developing organism, the observed abundance of the auto-regulatory gene will show a 
different expression pattern (Figure 3.1B). While correlation of expression patterns does 
not imply a causal relationship, it is a useful tool for gauging the degree to which genes 
could be co-regulated. Commonly used techniques for profiling gene expression includes 
two PCR methods: semi-quantitative RT-PCR and quantitative real-time PCR. 
Semi-quantitative RT-PCR profiling 
With semi-quantitative RT-PCR profiling, RNA from a sample is extracted, reverse 
transcribed to cDNA, and then the cDNA is used as a template for PCR amplification. 
This doesn’t use any special dyes or equipment and is visualized on a standard agarose 
gel with ethidium bromide (EtBr) staining. In most cases, the goal with PCR is to 
generate as much of the target DNA as possible. However, the geometric expansion of 
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PCR produces so much DNA that when the bands are visualized, the image may be 
saturated, showing only whether or not a band is present, but making it difficult to see if 
one sample had more or less DNA originally. With semi-quantitative RT-PCR, the goal is 
to generate an amount of DNA that falls below the saturation point of the PCR 
conditions, but enough to still allow the visualization of a band. This way is it possible to 
determine the relative amount of DNA in one sample compared to another. One method 
for adjusting the amount of DNA produced with PCR is controlling the number of cycles 
of PCR amplification. A common number of cycles for saturating PCR amplification to 
completion is 40. In semi-quantitative RT-PCR, this may be adjusted to be between 25-
35. This doesn’t produce an absolute number, but it does allow for rough quantification 
of one gene relative to another. Because it doesn’t require any extra equipment or dyes, it 
is also a great deal cheaper than more quantitative methods. 
Quantitative real-time PCR 
Quantitative real-time PCR (qPCR), on the other hand, does allow for the absolute 
quantification of an RNA molecule present in a sample (Heid et al. 1996). With qPCR, 
like RT-PCR, RNA is extracted from a sample and reverse transcribed to cDNA. This 
cDNA is then used as a template in PCR amplification. With qPCR, however, this is done 
in the presence of special dyes that measure the quantity of DNA present for each cycle 
of the PCR amplification. In order for the quantity to be measured after each cycle, the 
reaction takes place in a special real-time PCR machine that includes optics necessary to 
measure the fluorescence of the dyes (Wittwer et al. 1997). The amount of fluorescence 
of the dyes corresponds to the amount of DNA present in the reaction. With each cycle of 
PCR amplification, more and more DNA is produced, which causes an increase in  
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A 
 
 
B 
 
 
Figure 3.1 – Model of gene expression for an auto-regulatory gene in a developing 
organism 
This is a predicted model of gene expression for an auto-regulatory gene. A) In this 
model, the expression of a gene is only dependent upon the abundance of a gene in the 
prior time point. The abundance of the gene eventually plateaus to a constant level. The 
gene is assumed to be expressed ubiquitously in the sample. B) In this model, the 
expression of a gene is still dependent on the abundance of a gene in the prior time point. 
However, this adds the assumption that the gene of interest is only expressed in a 
particular cell population that makes up a smaller and smaller percentage of the organism 
as time progresses. In this model, the abundance increases until the plateau stage is 
reached. After this point, the abundance appears to decrease, relative to the size of the 
organism.
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fluorescence. There are a number of dyes used in qPCR, but one of the most common is 
quantification using the commercially available dye SYBR Green (Invitrogen) 
(Schneeberger et al. 1995; Wittwer et al. 1997). SYBR Green preferentially binds double 
stranded DNA over single-stranded DNA, which makes it a good choice for detecting the 
presence of double-stranded PCR products. 
The abundance of DNA in a sample can be quantified using the Ct method (Livak 1997). 
When fluorescence is plotted relative to the PCR cycle, there is a region during each 
reaction when amplification isn’t limited by reagent concentrations and fluorescence 
increases exponentially. When plotted on a logarithmic scale, this is called the log-linear 
region. A threshold line can then be set that represents a constant amount of fluorescence 
across all samples. This line is usually set within the log-linear region. When the 
intersection of this line with the amplification plot is projected onto the cycle axis, the 
threshold cycle (Ct) is determined. This doesn’t need to correspond to a discrete cycle, 
and can be a partial cycle. The Ct value is the theoretic cycle where all samples have the 
same amount of DNA present. When combined with a standard curve, this value makes it 
possible to calculate how much DNA was present in the initial preparation (C0). 
Based on the initial microarray results (Chapter 2), and an early version of the CrossGene 
database (Chapter 4), 34 genes were selected for profiling with semi-quantitative RT-
PCR. These experiments were performed using a prototype of the CrossGene database 
(Chapter 4) that wasn’t as comprehensive or complete. Because of this, candidate genes 
were selected using a slightly different methodology than that described in Chapter 2. 
Even when using these different criteria, the 5 genes selected for qPCR profiling were 
also present in the list of potential targets detailed in Chapter 2: Zic5, HBox1, CHN1, 
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Bix2, and Mix1. The expression pattern of these genes was then compared with the 
expression pattern of Nkx2-5 to determine the correlation. 
Methods 
Candidate gene selection 
Using the microarray results presented in Chapter 2, candidate genes were selected for 
further analysis using a combination of statistical and annotation criteria (Table 3.1). 
Probe sets were assigned a Xenopus laevis UniGene cluster ID by comparing the probe 
set’s target sequence to Xenopus laevis UniGene build 66 using the BLASTN algorithm 
(Altschul et al. 1990a; Altschul et al. 1997a). After statistical filtering, candidate genes 
were filtered by the presence of a consensus Nkx2-5 binding site ([TC]AAGTG) in the 
corresponding Xenopus tropicalis promoter (up to 2,000 bp upstream of the annotated 
transcriptional start site). Because CrossGene was not yet available, instead of using the 
CrossGene reciprocal groups to find orthologs, only orthologs from Homo sapiens, Mus 
musculus, and Rattus norvegicus were considered. Orthologs were found by TBLASTX 
comparison of the representative Xenopus laevis UniGene cluster sequence for a probe 
set to the UniGene clusters for the other organism. The single best match was taken as the 
ortholog, regardless of reciprocity. GO annotations for the orthologous genes were 
obtained from the NCBI Gene database (Maglott et al. 2007). For each Xenopus laevis 
gene, if any of the orthologs were annotated with the GO terms listed in Table 3.2, the 
Xenopus laevis gene was considered to share that annotation. 
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Table 3.1 – Selection criteria for candidate genes 
These are the selection criteria used to determine which candidate genes were to be 
profiled using semi-quantitative RT-PCR. First genes had to be called “present” in at 
least 5 out of 6 Nkx2-5 injected samples. Next, genes needed to have an absolute fold 
change greater than 1.5X and a FDR less than or equal to 0.1. Then, genes without a 
consensus Nkx2-5 binding site in the promoter of the gene were removed (using Xenopus 
tropicalis promoters 2,000 bp upstream of the predicted start site). This resulted in 318 
genes. From these, the only genes that were kept were a) annotated with a heart related 
GO term (Table 3.2), b) enriched in Nkx2-5 samples and were annotated as having 
transcription factor activity (Table 3.2), or c) predominantly in the “head” region (Table 
2.1). This resulted in 34 candidate genes. 
Criteria  Matching 
No filter  15,503 
Present in Nkx2-5 samples 
(Absent/Present filter) 
!0.83 10,402 
Fold change ±1.5X 826 
FDR q-value "0.1 509 
Consensus Nkx2-5 binding site 
present in 2,000 bp upstream 
 318 
a) GO: Heart  10 
b) GO: Transcription factor and 
enriched in Nkx2-5 samples 
 17 
c) Predominantly in “head” 
samples  
 11 
Unique candidate genes  34 
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Table 3.2 – GO terms used for candidate gene selection 
The human, mouse, or rat homologs of a Xenopus laevis transcript had to be annotated 
with one of these GO terms in order to be considered for further testing. For this 
selection, all of the first four GO terms were all considered “Heart”-related. 
Description  GO Term 
Heart development GO:0007507 
Embryonic heart tube development GO:0035050 
Heart morphogenesis GO:0003007 
Regulation of heart contraction GO:0008016 
Transcription factor activity GO:0003700 
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Semi-quantitative RT-PCR profiling 
Primers for semi-quantitative RT-PCR profiling were designed for each gene 
algorithmically using Primer3 software with the parameters listed in table A1.1 (Rozen et 
al. 2000). The target product size was 1,000 bp using the 3’ half of the UniGene sequence 
as the template. Total RNAs were collected as previously described from pools of 
Xenopus laevis embryos at the following stages and adult tissues: Unfertilized egg, St. 9, 
St. 10.5, St. 11, St. 11.5, St. 12, St. 14, St. 16, St. 18, St. 21, St. 26, St. 28, St. 30, St. 32, 
St. 35, spleen, liver, heart, and skeletal muscle. 10 µg of each RNA sample was reverse 
transcribed into cDNA using a SuperScript II Reverse Transcriptase kit (Invitrogen) in a 
40 µl reaction using anchored oligo-dT as a primer. The resulting cDNAs were diluted 
12.5X to 500 µl yielding a concentration of 20 ng/µl. Next, for each gene, 5 µl of the 
diluted cDNAs were amplified by PCR using Platinum Taq DNA polymerase 
(Invitrogen) using the following PCR conditions: 94°C for 2 minutes; 35 cycles of 94°C 
for 30 seconds, 55°C for 30 seconds, 72°C for 75 seconds; followed by 72°C for 2 
minutes. PCR products were visualized with agarose gel electrophoresis and EtBr 
staining. ODC (NCBI Gene ID: 379859) and #-actin (NCBI Gene ID: 398459) were used 
as internal controls. 
Quantitative real-time PCR profiling 
Primer design 
Since quantitative real-time PCR is very sensitive to genomic DNA contamination, it is 
advantageous to design PCR primers that span an exon/exon boundary. As previously 
described in Chapter 2, genomic assemblies for Xenopus tropicalis were used as an 
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analog for Xenopus laevis genomic sequence. The annotations for Xenopus tropicalis 
predicted transcripts also include predicted exon locations. For CHN1, Zic5, HBox1, 
Bix2, GAPDH, and Nkx2-5, new primer pairs were designed using Primer3 software 
(Rozen et al. 2000) with a target PCR product size of 150-225 bp. Additionally, for all 
genes except Nkx2-5, the primers were designed to include the last predicted exon/exon 
boundary. For Nkx2-5, the primers were designed against the full length of gene. Then, 
using custom written software, potential PCR products were predicted for each primer 
pair using all Xenopus laevis UniGene clusters as the template. Up to two mismatches 
were allowed, to allow for flexibility in the PCR product predictions. Only primer pairs 
that were predicted to have a single product were selected. For ODC and Mix1, this 
strategy failed to produce confirmable PCR products, so previously published qPCR 
primers were used instead (Heasman et al. 2000; Xanthos et al. 2001).  
Cloning control PCR fragments  
Each primer pair was confirmed by PCR to produce a single band of the appropriate size 
using either pooled St. 10.5 cDNA or St. 45 cDNA. For PCR amplification, recombinant 
Taq polymerase (Invitrogen) was used with the following PCR reaction conditions: 94°C 
for 3 minutes, followed by 40 cycles of 94°C for 30 seconds, 55°C for 30 seconds, and 
72°C for 30 seconds. PCR products were visualized with agarose gel electrophoresis with 
EtBr staining as described in Chapter 2.  
The PCR products were then purified using a QIAquick PCR purification kit (Qiagen, 
Valencia, CA) and cloned into a pCRII plasmid using a TOPO TA Cloning kit 
(Invitrogen) and transformed into DH5$ E. coli cells (Invitrogen). Colonies were then 
selectively grown on LB/agar plates containing 100 µg/ml of ampicillin (Sigma-Aldrich, 
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St. Louis, MO). Individual colonies were picked and grown in 4 ml of LB broth 
(Invitrogen). Plasmids were then purified using a QIAprep spin miniprep kit (Qiagen) 
and their inserts confirmed by PCR using gene specific and generic M13 primers. PCR 
was performed as described above, with the exception that with M13 primers, the 
extension step was extended to 45 seconds. 
The cloned control PCR products were linearized by incubating 1 µg of the plasmid in a 
20 µl reaction containing 2 µl 10X Buffer D (6 mM Tris-HCl, pH 7.9; 150 mM NaCl; 6 
mM MgCl2; 1 mM DTT) and 10 U NotI restriction enzyme (Promega, Madison, WI). The 
reaction was incubated at 37°C for one hour, followed by heat inactivation of the enzyme 
by incubating the mixture at 65°C for 15 minutes. Serial dilutions were then made of this 
reaction mixture. These dilutions served as the basis for standard curves in the subsequent 
quantitative real-time PCR assays so that each gene could be quantified. 
RNA extraction from fixed embryos 
For qPCR analysis, six embryos from each of the following stages were used: St. 11, St. 
17, St. 22, St. 28, and St. 45. RNA was extracted from embryos previously fixed in 
NOTOXhisto (Scientific Device Laboratory, Des Plaines, Illinois) and stored at 4°C. For 
these samples, individual embryos were removed from methanol, placed in a 
microcentrifuge tube containing 100 µl of Proteinase K buffer (0.1 M NaCl, 10 mM Tris-
HCl pH 8, 1 mM EDTA, 0.5% SDS), homogenized with a tube pestle, and incubated for 
90 minutes with 1.5 µl Proteinase K (20 mg/ml) (Ambion) in at 50°C while being 
agitated. RNA was then extracted and cDNA synthesized using the same TRIzol 
procedure detailed in Chapter 2. After cDNA synthesis, the cDNAs were diluted to a final 
concentration of 5 ng/µl. 
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Real-time qPCR profiling 
Real-time qPCR was performed using the Roche LightCycler® 480 (Roche Applied 
Science, Indianapolis, IN) using the Express SYBR GreenER qPCR mix with ROX 
(Invitrogen). All reactions used the following PCR conditions: 95°C for 5 minutes and 45 
cycles of 95°C for 10 seconds, 60°C for 5 seconds, 72°C for 10 seconds. Data acquisition 
was performed after the 72°C extension step for all PCR cycles. After the PCR cycles 
were complete, melting curve analysis was performed to confirm product quality. The 
reaction conditions for each well were: 10 µl master mix, 0.4 µl gene-specific primers 
(100 pmol/µl), 5.6 µl water, and 4 µl of template (cDNA or diluted linearized plasmid). 
For each gene tested, two 96 well plates were used. Only one gene was tested per plate. 
The first plate contained cDNAs for stages 11, 17, and 22. The second contained cDNAs 
for stages 28 and 45. Each stage was represented by 6 biological replicates (individual 
embryos) with 4 technical replicates each (24 total wells). Each plate also contained 4 
non-template negative control wells and a standard curve. The standard curve was made 
up of seven 1:10 serial dilutions of the cloned control PCR products (from 10-4 to 10-10) in 
duplicate. For these wells, the number of copies present in each well was calculated based 
upon the concentration of DNA, as measured by a NanoDrop spectrophotometer 
(Ambion), and the molecular weight of the cloned control PCR fragment (Figure 3.2).  
Measuring RNA abundance 
Ct values were calculated using a technique similar to that described by Ramakers, et al 
(Ramakers et al. 2003). For each well, background was calculated as the minimal amount 
of fluorescence measured for the well. Background was then subtracted from the 
fluorescence values and the fluorescence value was log transformed. The log-linear range 
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B !"#$%& ! !!"#!! !"!" !! ! !!"#!!"#$ !"#$! !! ! !!!!!!" !!!!"#$%&!!! 
 
Figure 3.2 – Equations for calculating copy number from concentration and size of 
a DNA fragment 
A) Calculating the mass of a linearized plasmid based on the total size of the fragment 
(bp) and the average mass of a fragment (1.1e-21). B) The number of copies in a sample 
can be calculated using the mass of the fragment and the concentration of DNA in a 
sample.
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was found by removing the initial lag-phase and ending plateau phase PCR cycles 
(Figure 3.3). The optimal linear regression that encompassed three or more points in the 
log-linear range was then calculated (Figure 3.3). This resulted in an upper and a lower 
bound for the linear range. For each plate, a threshold line was picked that fell within the 
upper and lower bounds for the linear ranges of all samples (Figure 3.4). The threshold 
for each plate was determined independently. If the log-linear range for a well could not 
be found, started past cycle 40, or had a linear regression slope more than 4 standard 
deviations away from other wells, that well was discarded and not used in further 
analysis. The point where the threshold line crossed the log-linear range is called the Ct 
value and was calculated using the equation of the optimal linear regression. 
The standard equations for describing PCR amplification are given in Figure 3.5 
(Ramakers et al. 2003). Once Ct values were found for each well, a standard curve was 
calculated by plotting the Ct value of the standards versus the log10-transformed copy 
number. Next, a linear regression was calculated to find the line that best fit the data 
(Figure 3.6). The equation describing this line was then used to calculate the initial 
number of copies present at C0 in each sample (Figure 3.5B). Mean copy number was 
then calculated for technical replicates. Copy number was then normalized to ODC 
across samples by dividing the copy number for each gene by the copy number of ODC 
in each sample. Normalizing helps to minimize variability when comparing one sample 
to another. Using the normalized copy numbers for each biological sample, correlation to 
the expression pattern of Nkx2-5 was then calculated using the Pearson sample 
correlation coefficient (Figure 3.7).  
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Figure 3.3 – Slope finding in a qPCR sample 
In this example well, background corrected fluorescence values were plotted on a 
logarithmic scale versus the cycle number. An upper and lower bound (black) for testing 
linear regressions were calculated based on finding a starting and ending regions, 
representing the initial lag-phase and the non-linear ending plateau. Linear regressions 
were then calculated within this region for all consecutive sets of three or more cycles. 
The best fitting regression is then plotted (green). The upper and lower bounds of the 
points that make up the best-fit regression are marked in red and blue, respectively.  
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Figure 3.4 – Ct finding for a qPCR plate 
The log-linear and linear regression lines plotted for an entire plate, including the 
standard curve. The lines and colors are as described in Figure 3.3. In this case, a 
threshold cycle (Ct) was determined by taking the mean between the lowest upper bound 
and the highest lower bound (purple). This line represents a constant amount of DNA 
present in all samples and is used to calculate the amount of DNA initially present in each 
sample.  
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A !! ! !! ! !!  
B ! ! ! !!"# ! !"# !! ! !"# !!!"# !  
C ! ! !"! !!"#$% 
Figure 3.5 – Equations describing PCR amplification 
A) The amount of DNA present after cycle C is determined by two factors – the amount 
of starting material (N0) and the efficiency of the PCR reaction (E). B) Equation A, log-
transformed. This shows the linear relationship between an arbitrary cycle C and the 
amount of starting material (N0). If the E is constant, a linear regression can be used to 
determine both E and N0. C) E can be found using the slope of the linear regression.
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Figure 3.6 – Standard curve plot 
A standard curve was plotted for an example plate. Ct values were plotted against the log-
transformed copy number for seven different 1:10 dilutions of cloned control DNA (!). 
The Ct values for the unknown samples (%) were then overlaid on the standard curve and 
initial copy-number determined. Copy number was calculated using the linear regression 
equation.  
            83
  
!!"##$%&'(")! !!! ! !!! ! !!!!! ! !!!!!!!!! ! !!!!!!! !!! ! !!!!!!!  
Figure 3.7 – Pearson sample correlation coefficient 
Given two genes X and Y measured with N conditions, the correlation between the two 
genes can be calculated using the above equation.
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Results  
After an initial analysis of the microarray data, 34 candidate genes were selected to be 
profiled using RT-PCR (Table 3.3). One of the candidates (Xl.13885.1.A1_s_at) could 
not be amplified with any cDNA template and was dropped. The remaining 33 candidate 
genes were profiled using semi-quantitative RT-PCR and visualized using agarose gel 
electrophoresis (Figure 3.8). Genes were ordered by their annotation classification.  
Five of these genes were then selected for qPCR profiling by visual inspection of the RT-
PCR profiles: Bix2, CHN1, Mix1, HBox1, and Zic5. Two of the selected genes were 
down-regulated with Nkx2-5 over-expression (Bix2 and Mix1), and the remaining three 
were up-regulated. Two were annotated as heart-related (Bix2 and Mix1), one was 
annotated as transcription-related (HBox1), and the last two were annotated as 
predominantly expressed in the head-region (CHN1 and Zic5). HBox1 had an expression 
pattern that seemed to mirror that of Nkx2-5, as did Zic5 (Figure 3.8). On the other hand, 
CHN1 was only found in heart cDNA. The rough expression pattern of Bix2 seemed to 
be the opposite of Nkx2-5, whereas Mix1 had an erratic expression pattern. Overall, it 
was felt that these genes represented a good cross-section of the original candidates.  
Additionally, Nkx2-5 was included as a positive control and so that correlations to its 
expression pattern could be made. ODC was included as a housekeeping reference gene 
and GAPDH was included as a negative control. GAPDH is commonly used as a 
housekeeping reference gene, but under the variety of developmental stages profiled, its 
expression is highly variable (Sindelka et al. 2006). The size and concentration of cloned  
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Figure 3.8 – Semi-quantitative RT-PCR profile of selected genes 
Selected genes were profiled using semi-quantitative RT-PCR with cDNA from a variety 
of developmental stages and adult tissues. Genes are identified using their UniGene 
cluster IDs and marked on the left side by their classification: heart-related (Heart), 
predominantly expressed in the head (Head), or transcription-related (TF). The 
housekeeping genes ODC and !-actin were used as controls. Genes selected for qPCR 
profiling marked with (*). Three genes unexpectedly had multiple bands present (Xl.397, 
Xl.146, and Xl.823). It is unknown if these bands represented different splice variants or 
contamination. For all samples, 35 cycles of PCR amplification were performed.
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standards were used to calculate the number of copies present in the undiluted standards 
(Table 3.4). 
The selected 8 genes were then qPCR profiled using a serial dilution standard curve and 
cDNA from stages: St. 11, St. 17, St. 22, St. 28, and St. 45. Standard curves were 
calculated using linear regression (Figure 3.9) and the number of copies present in each 
of the staged cDNAs was calculated (Table 3.5). These values were normalized to the 
amount of ODC present in each biological replicate (Figure 3.10). The expression 
patterns of each gene were then correlated to the expression pattern of Nkx2-5 (Figure 
3.11, Table 3.6).  
The expression patterns of Zic5 and HBox1 both correlated well to the pattern of Nkx2-5, 
whereas Mix1 and Bix2 were both down-regulated and not correlated. CHN1 was only 
marginally correlated, but still had a very large fold change, which might indicate that 
there was a secondary mechanism driving the changes in expression of CHN1. 
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Table 3.4 – The number of copies present in the control standard curves 
The total sizes of the linearized control plasmids were calculated by adding the sizes of 
the insert with the size of the pCRII plasmid (3,973 bp). Then, using the equations in 
Figure 3.2, the measured concentrations, and a constant volume of 4 µl the number of 
copies in the undiluted control samples were calculated. 
Gene Insert (bp) Total (bp) Mass g/copy Conc (ng/µl) Copies  
Nkx2-5 196 4,169 4.57E-018 94.8 8.299E+10 
Bix2 182 4,155 4.55E-018 110.9 9.741E+10 
CHN1 169 4,142 4.54E-018 99.4 8.758E+10 
HBox1 209 4,182 4.58E-018 109.6 9.565E+10 
Mix1 188 4,161 4.56E-018 107.4 9.420E+10 
Zic5 147 4,120 4.52E-018 130.4 1.155E+11 
ODC 221 4,194 4.60E-018 110.6 9.624E+10 
GAPDH 195 4,168 4.57E-018 113.3 9.921E+10 
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Nkx2-5  
  
 
Bix2 
 
  
Figure 3.9 – Standard curves for qPCR profiled genes 
Standard curves were plotted for each plate from each profiled gene. Each gene required 
two plates and standard curves were calculated for each plate independently. The cloned 
control plasmids were serial diluted (!) to form a standard curve. Ct values for the 
unknown samples were then projected onto the standard curve (") and the number of 
copies in each of the staged cDNAs was calculated. Outliers in the serial dilutions were 
observed manually and disregarded (*).  
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CHN1  
  
 
HBox1 
 
  
Figure 3.9 (continued)  
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Figure 3.9 (continued)  
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ODC  
  
GAPDH  
  
Figure 3.9 (continued)  
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Figure 3.10 – qPCR expression profiles of selected genes (normalized to ODC)  
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Figure 3.10 (continued) 
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Figure 3.10 (continued) 
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Figure 3.10 (continued)  
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Figure 3.11 – Expression profile correlation with Nkx2-5 
The Pearson correlation coefficient plotted for each of the profiled genes along with the 
fold change from the Nkx2-5 overexpression microarray (Chapter 2). The genes that had 
a greater fold change also had a better correlation to the expression profile of Nkx2-5.   
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Table 3.6 – Correlation of expression profiles to Nkx2-5 
For each gene, the Pearson correlation coefficient was calculated, comparing its 
expression profile to that of Nkx2-5. Values greater than 0.6 are considered correlated. 
Gene Correlation 
Bix2 -0.28 
CHN1 0.48 
HBox1 0.89 
Mix1 -0.30 
Zic5 0.85 
GAPDH -0.43 
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Discussion 
Expression profiling is not a technique that can alone determine if genes are regulated by 
Nkx2-5. Profiling can imply that genes, which share a common expression pattern, may 
be regulated through similar mechanisms. Nkx2-5 is auto-regulatory, so Nkx2-5 may be 
the common regulator. But this guilt-by-association cannot be used to infer causality.  
One thing that would have strengthened the profiling analysis would have been the ability 
to use a greater number of conditions. The semi-quantitative RT-PCR had 19 different 
stages and tissues. Because of this, the semi-quantitative profile gave better overview of 
the early expression of the 33 genes that were profiled. While the semi-quantitative 
profile gave a good overview, it wasn’t accurate enough to be able to calculate expression 
pattern similarities.  
The obvious choice then is to use more quantitative real-time PCR to quantify the exact 
number of copies of the target RNA molecule in each sample, as qPCR yields a much 
more accurate profile. To generate good data, it is important to use multiple biological 
replicates and multiple technical replicates. This was even more critical for low 
abundance genes where wells might be discarded when removing wells for quality 
control issues. Unfortunately, qPCR is an expensive technique to use to profile genes, 
limiting the number of genes and conditions available for testing. 
The Roche LightCycler 480 has its own preferred technique for quantifying the amount 
of RNA in a sample: the second derivative max method (Wittwer et al. 1999; Luu-The et 
al. 2005). This method uses the maximum point of the second derivative in the growth of 
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fluorescence to determine a crossing point (Cp). The Cp is analogous to the Ct value that 
was calculated. The second derivative max method has two problems. First, it is very 
difficult to manually calculate, making it impossible to verify the results obtained from 
the software. Second, the method requires modeling the entire span of the exponential 
phase of the PCR reaction. Because of this, it may not be appropriate to use when 
measuring a target with very low abundance (on the order of 1,000 copies per sample). 
Because of these factors, it was determined that calculating Ct values was preferred. By 
calculating Ct values, it was possible to measure rare targets and still have good 
reproducibility. This was evident from the R2 values of the standard curves. Every gene, 
except GAPDH, had a linear regression that fit the standard curve well. GAPDH 
measurements proved to be quite variable, and this reinforced why it was not chosen as a 
reference gene. 
The qPCR analysis was limited by costs and reagent availability, but it nevertheless 
yielded some interesting results. The expression profiles of both Zic5 and HBox1 were 
highly correlated to the expression levels of Nkx2-5 and both were significantly up-
regulated in the Nkx2-5 over-expression microarrays. Together, these two things imply 
that Nkx2-5 may have at least an indirect regulatory effect on these two genes.  
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CHAPTER 4: CONSTRUCTION AND USE OF THE CROSSGENE 
ANNOTATION DATABASE 
Introduction 
Modern studies in molecular biology increasingly require genomic scale analysis. The 
Achilles heel of genomic scale analysis is the quality of functional annotation, which 
varies widely from organism to organism. Specific organisms may be more widely 
studied in a particular domain, but not in others. The mechanisms of developmental 
biology, for instance, are often studied in model organisms such as fruit fly, mouse or 
frog and the relevant genes annotated primarily for these organisms. Genes associated 
with human disease will be annotated primarily in humans. This leads to gaps in 
annotation of even the most widely studied organisms.  
One method for annotating unknown genes is to search for known protein domains within 
DNA or amino acid sequences. This approach is useful for a fraction of possible 
annotations, particularly cellular localization signals, protein-protein interaction domains, 
and DNA binding domains. It may miss larger biological processes or molecular 
functions. For example, finding a DNA binding domain suggests that a protein is likely to 
bind DNA, but does not reveal the effect of that binding. Additionally, orthologous 
proteins may gain or lose domains, and the effect of those domains may differ between 
organisms. 
A common method for filling gaps in annotation is to compare gene or protein sequences 
from one organism to another. For example, to understand a gene expression experiment 
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carried out in the frog, Xenopus laevis, one might find the best match for each frog gene 
in human or mouse. However, this approach can also lead to problems. How does one 
best determine which organism to use as the reference? How does one set a threshold to 
say which genes are likely to be orthologs and which are questionable? 
Another way to fill gaps in annotation is to find orthologous genes from multiple 
organisms. Examples include the Clusters of Orthologous Groups (COG) and euKaryotic 
clusters of Orthologous Groups (KOG) (Tatusov et al. 1997; Tatusov et al. 2003), the 
TIGR Orthologous Gene Alignments (TOGA) now known as Eukaryotic Gene 
Orthologues (EGO) (Lee et al. 2002), RoundUp (Deluca et al. 2006), OrthoMCL (Li et 
al. 2003), and HomoloGene (Wheeler et al. 2008). Each of these databases uses a 
different technique for finding orthologs. COG/KOG, RoundUp and OrthoMCL all use 
protein sequences as the basis of their comparisons. EGO is based upon tentative 
consensus (TC) sequences derived from ESTs. COG/KOG, EGO, and OrthoMCL all use 
a BLAST approach to find similar sequences, whereas RoundUp uses the reciprocal 
smallest distance algorithm (RSD) (Wall et al. 2003). Each of these has their strengths 
and weaknesses. COG/KOG and EGO haven’t been updated since 2003 and 2006, 
respectively, and HomoloGene requires fully sequenced genomes. While RoundUp and 
OrthoMCL each have a large number of genomes (533 and 138 as of February 2010), the 
majority are prokaryotic and neither includes the common model organism, Xenopus 
laevis, in their index. Also, because of the large number of genomes, RoundUp 
orthologous clusters must be computed on the fly, which can be time consuming. 
In an attempt to overcome the problems listed above and improve gene annotation, we 
developed the CrossGene database. CrossGene currently includes data from 8 commonly 
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studied eukaryotes: Homo sapiens, Mus musculus, Rattus norvegicus, Gallus gallus, 
Xenopus laevis, Danio rerio, Drosophila melanogaster, and Caenorhabditis elegans. The 
full-length transcript sequences from each of these organisms were compared to all of the 
others using the BLAST family of algorithms (Altschul et al. 1990b; Altschul et al. 
1997b). These homologies were then combined into one database. By comparing whole 
transcripts, we can identify orthologous genes or gene families across multiple species. 
Since genes with similar sequences are likely to have similar functions in different 
organisms, we then combine existing Gene Ontology (GO) annotations (Ashburner et al. 
2000a; Consortium 2004a) for all members of the orthologous group to improve the 
functional annotation for each of the organisms included. Transferring annotation from 
one gene to another based on homology can have problems; for example, orthologs may 
differ in function between different organisms. However, relying on networks of 
reciprocal best-matches to establish cross-species homology, rather than on individual 
matches, should increase the reliability of the annotation. 
Methods 
Sequence retrieval and processing 
UniGene clusters were treated as representative of the complete transcriptome for an 
organism (Wheeler et al. 2008). The unique UniGene cluster sequences were retrieved 
from NCBI (Table 4.1) and formatted into BLAST databases. Once in a common format, 
each sequence was compared to all of the databases. For cross-species  
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Table 4.1 – Sources of data included in CrossGene 
Data set   Source Date retrieved 
H. sapiens UniGene 218 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
M. musculus UniGene 178 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
R. norvegicus UniGene 179 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
G. gallus UniGene 41 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
X. laevis  UniGene 86 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
D. rerio UniGene 115 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
D. melanogaster UniGene 63 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
C. elegans UniGene 43 ftp://ftp.ncbi.nih.gov/repository/UniGene 2009-05-05 
 
 
Gene Ontology Terms http://genenontology.org/ontology 2009-06-09 
UniProtKB identifier mappings 
ftp://ftp.uniprot.org/pub/databases/uniprot/
current_release/knowledgebase/idmapping
/idmapping.dat.gz 
2009-06-09 
EBI Gene Ontology Annotation http://www.ebi.ac.uk/GOA 2009-06-09 
(CrossGene build 0904)  
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comparisons, the TBLASTX algorithm was used. For comparisons within the same 
organism, the BLASTN algorithm was used. Raw blast results were parsed and stored in 
a MySQL relational database.  
Best-match calculations 
For each transcript, the blast hit with the lowest e-value for each other organism was 
defined as the “best-match.” In the case of a tie, the blast hit with the best score was taken 
as the overall best-match. To further characterize the matches, if an e-value was within 
10% of the log-transformed best-match e-value, it was deemed to be a “high-quality 
match.” This was an arbitrary threshold. For this calculation, e-values of 0 were 
arbitrarily treated as 1e-200. For example, if the best-match of a transcript had an e-value 
of 1e-100, a high-quality match needed to have an e-value between 1e-100 and 1e-90. If 
two transcripts were best matches or high-quality matches for each other, they were 
called “reciprocal best-matches” or “reciprocal high-quality matches.” These are also 
known as reciprocal best blast hits. 
Reciprocal group assembly 
Once best-matches and high-quality matches were calculated for each transcript, these 
results were used to calculate reciprocal groups for both best and high-quality matches. 
Any given transcript could belong to only one reciprocal best-match and one reciprocal 
high-quality group. For re-annotation, CrossGene assembled networks of reciprocal 
groups consisting linked reciprocal matches. For best-match groups, a new group was 
started with a random, unassigned, seed transcript. Then all of the reciprocal best matches 
for that transcript from other organisms were added to the group. Then all of the 
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reciprocal best matches for those transcripts were also added to the group. This continued 
recursively until all of the linked best-matches were added to the group. Because the 
graph was built by exhaustively traversing the reciprocal matches, the contents of a 
cluster were the same regardless of the order of seed transcripts. High-quality groups 
were formed in the same manner, except that they included linked high-quality reciprocal 
matches. Once a reciprocal group was assembled, the number of members from each 
organism was tallied. For reciprocal groups with more than one member but less than 
100, a graphical representation was prepared using the dot and circo GraphViz layout 
programs (Gansner et al. 2000; Gansner et al. 2007). 
GO annotation 
The gene ontology (GO) term hierarchy was downloaded from the Gene Onotology 
Consortium (Ashburner et al. 2000a; Harris et al. 2004). GO terms were associated with 
transcripts by first mapping UniProtKB IDs to the UniGene cluster ID or alternatively the 
NCBI Gene ID of a CrossGene transcript using the UniProtKB “idmapping” datafile 
(Table 4.1). It was possible for multiple UniProtKB IDs to map to a single CrossGene 
transcript. Next, unfiltered GO annotations were retrieved from the EBI Gene Ontology 
Annotation database (GOA) (Camon et al. 2004a) for all organisms (Table 4.1). The 
UniProtKB identifier was then used to associate GO annotations to a CrossGene 
transcript. Because GO terms are in a hierarchy, reported annotation counts include non-
redundant parent terms in their totals. 
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GO rescue and HomoloGene comparisons 
For each organism, known GO terms were used to determine if they could be recovered 
using CrossGene reciprocal group GO annotations. Any GO annotation associated with a 
gene that was a member of non-singleton group was considered possible for recovery. If 
that annotation was present in another member of the reciprocal group (in a different 
organism), the annotation was rescued. Annotation evidence was also taken into account. 
If an annotation had a non-IEA evidence code and could be rescued by another non-IEA 
annotation, it was added to the non-IEA rescue counts. 
Pairs of orthologous genes were extracted from NCBI HomoloGene and compared to 
CrossGene best-match and high-quality reciprocal groups. If both NCBI Gene IDs of a 
HomoloGene pair was present in CrossGene, it was considered a possible pair. If each 
gene in the pair were a member of the same best or high-quality group, the pair was 
confirmed. Possible and confirmed pairs were also categorized by organism pair. 
Results 
Interface and searching 
CrossGene is available through a web interface with a section for individual transcripts 
and a section for reciprocal groups. The transcript section contains all of the previously 
known information for a transcript (Figure 4.1), including the sequence, other database 
identifiers (UniGene, GenBank, NCBI Gene, and UniProt), BLAST results (Figure 4.2), 
and existing GO term annotation. Each transcript also has a link to its best-match and 
high-quality reciprocal group. The interface for reciprocal groups is divided into three 
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areas: an overview (Figure 4.3), detailed member matches (Figure 4.4), and the GO term 
annotations for the group (Figure 4.5). Associated GO terms are also given a score, which 
is the number of evidence records linking the GO term to a member of the reciprocal 
group. The database can be queried with two methods: textual search or sequence based 
BLAST search. Any included database identifier, gene name, or keywords can be used to 
search the database for matches. The user can also upload a DNA sequence to compare 
with the included transcripts via the BLASTN algorithm. 
In addition to the primary web interface, there is also a web API for retrieving data 
(Table 4.2). Complete annotations for all reciprocal groups and reciprocal group based 
GO annotations by organism can also be downloaded in a tab-delimited format. 
Reciprocal group assembly 
The number of members in a best-match group is highly variable (Table 4.3); however, 
each transcript belongs to one and only one group. Because high-quality groups were 
based on the less stringent reciprocal high-quality matches, they potentially yield much 
larger groups (Table 4.3) and graphs (Figure 4.6). While the majority of transcripts have 
no reciprocal best match, for each organism there is a core set of transcripts that have at 
least one reciprocal match (Table 4.4). In human, there are 19,862 and 23,406 transcripts 
with one or more best and high-quality reciprocal matches, respectively. These numbers 
correlate well with the estimated 20,000-25,000 protein coding genes present in the 
human genome (Consortium 2004b). Transcripts without a reciprocal match could 
indicate truly unique genes but more likely represent ESTs included in the UniGene 
database which are not protein coding.
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Figure 4.1 – Screenshot showing the best-matches and transcript overview 
Listing of each of the best matches for the transcript Xl.22859 from all of the organisms 
in the CrossGene database. From this screen you can see the known information about 
the transcript, including the UniGene cluster ID, NCBI Gene ID, NCBI Entrez accession 
numbers, and UniProt IDs. The final column for each best-match indicates whether or not 
the match is a reciprocal best-match, reciprocal high-quality match, or non-reciprocal 
best or high-quality match.  
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Figure 4.2 – Screenshot showing the BLAST results 
BLAST results for Xl.22859 against Homo sapiens. Raw blast results can be filtered by 
one or more organisms, e-value, best/high quality match status, or limited to a defined 
number of hits per organism.  
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Figure 4.3 – Reciprocal group overview screen 
This is a screenshot of the reciprocal group overview screen for reciprocal group 85. This 
shows the members of reciprocal group 85 as well as the dot and circo graphs illustrating 
the network structure for this reciprocal group. Dot and Circo are two graph layout 
algorithms provided by the GraphViz package (Gansner et al. 2000; Gansner et al. 2007). 
Depending on the network structure, one may provide a more informative layout. 
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Figure 4.4 – Reciprocal group matches screen 
This is a screenshot shows the matches screen for reciprocal group 85. This is an 
unordered list of reciprocal matches that were traversed to build this reciprocal group. 
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Table 4.2 – HTTP API URLs 
Data URL 
Reciprocal group members http://crossgene.cmg.iupui.edu/recip/[id]?output=text 
Reciprocal group GO annotations http://crossgene.cmg.iupui.edu/recip/[id]/go?output=text 
Transcript annotation http://crossgene.cmg.iupui.edu/transcript/[id]?output=text 
Transcript sequence http://crossgene.cmg.iupui.edu/transcript/[id]/seq?output=text 
Transcript GO annotation http://crossgene.cmg.iupui.edu/transcript/[id]/go?output=text 
List of all sources http://crossgene.cmg.iupui.edu/sources?output=text 
Transcripts for a source http://crossgene.cmg.iupui.edu/source/[id]?output=text 
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Table 4.3 – Size of best-match and high-quality reciprocal groups 
Group members Best-match High-quality 
1000+ - 1 (1487) 
400-1000 - 4 
201-400 - 10 
101-200 - 30 
65-100 1 (97) 29 
51-65 9 47 
41-50 11 64 
31-40 30 140 
26-30 51 174 
21-25 168 317 
16-20 479 764 
11-15 1,624 1,653 
7-10 4,549 3,903 
3-6 7,441 5,879 
2 8,094 7,508 
1 303,773 283,707 
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GO annotation 
When looking at the total number of annotated transcripts, using best-match reciprocal 
groups to combine annotations yielded more annotated transcripts for all organisms 
(Table 4.5). As expected, the increase in number of annotated transcripts was greatest in 
organisms that originally had a lower percentage of annotated transcripts. For example, in 
Caenorhabditis elegans and Drosophila melanogaster, the two best-annotated organisms 
by percentage, there was only a net gain of 760 and 716 annotated transcripts, 
respectively. However, Xenopus laevis gained 4,260 additional annotated transcripts and 
Danio rerio gained 6,071. The number of annotated transcripts almost tripled for Gallus 
gallus. Even as well studied an organism as Rattus norvegicus gained 8,173 annotated 
transcripts, nearly doubling the previous annotations.  
In addition to increasing the number of annotated transcripts, the average number of 
annotations for each annotated transcript also increased dramatically for all organisms. 
Increases ranged from 46% in humans to over 280% in Xenopus laevis, and on average 
they doubled (Table 4.5).  
Robustness of GO annotations 
The quality of the reciprocal group GO annotations was tested by exploring the ability of 
CrossGene to rescue the known annotations of each organism (Table 4.6, Table 4.7). 
When the annotations of an organism were completely excluded, how well could 
CrossGene reconstruct those annotations using the information from the other organisms? 
If a gene was a member of a reciprocal group of more than one member, any known 
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Figure 4.6 – Best-match reciprocal group for Nkx2-5 
This is the graph representation of the best-match reciprocal groups containing the 
Xenopus laevis gene Nkx2-5. The widths of the edges are inversely proportional to the e-
value of the match. The best-match graph shows all of the cross-species genes 
homologous to Nkx2-5.  
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Nkx2-5
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Figure 4.7 – High-quality reciprocal group for Nkx2-5 
This is the graph representation of the high-quality reciprocal groups containing the 
Xenopus laevis gene Nkx2-5. The widths of the edges are inversely proportional to the e-
value of the match. Best-matches are drawn in solid lines and high-quality matches are 
drawn in dashed lines. The best-match graph (Figure 4.6) shows all of the cross-species 
genes homologous to Nkx2-5, whereas the high-quality group has expanded the network 
to include other Nkx2 family members in all other organisms, including Nkx2-1 through 
Nkx2-10.  
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Table 4.4 – Transcripts with at least one reciprocal best or high-quality match 
Organism # seq # best-match # hq-match 
H. sapiens 123,877 19,862 (16.0%) 23,406 (18.9%) 
M. musculus 79,021 23,852 (30.2%) 28,220 (35.7%) 
R. norvegicus 63,440 23,605 (37.2%) 26,816 (42.3%) 
G. gallus 33,383 13,999 (41.9%) 15,198 (45.5%) 
X. laevis  35,077 13,111 (37.4%) 15,393 (43.9%) 
D. rerio 51,506 15,464 (30.0%) 19,324 (37.5%) 
D. melanogaster 17,330 6,375 (36.8%) 7,137 (41.2%) 
C. elegans 22,015 5,608 (25.5%) 6,448 (29.3%) 
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Table 4.6 – GO annotation rescue (best-match) 
 All (incl. IEA) Non-IEA 
 Rescued Possible % Rescued Possible % 
H. sapiens 88,847 151,481 58.7% 15,622 57,034 27.4% 
M. musculus 87,423 125,867 69.5% 13,240 39,833 33.2% 
R. norvegicus 61,712 78,096 79.0% 8,990 24,645 36.5% 
G. gallus 25,211 28,067 89.8% 1,531 1,895 80.8% 
X. laevis  26,827 34,881 76.9% 1,325 2,158 61.4% 
D. rerio 29,164 46,950 62.1% 1,610 5,511 29.2% 
D. melanogaster 24,640 58,666 42.0% 4,455 24,031 18.5% 
C. elegans 18,568 51,425 36.1% 1,091 15,228 7.2% 
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Table 4.7 – GO annotation rescue (high-quality) 
 All (incl. IEA) Non-IEA 
 Rescued Possible % Rescued Possible % 
H. sapiens 78,113 129,746 60.2% 16,013 52,978 30.2% 
M. musculus 76,188 103,665 73.5% 13,657 37,629 36.3% 
R. norvegicus 54,404 67,314 80.8% 9,248 23,061 40.1% 
G. gallus 23,055 24,988 92.3% 1,582 1,872 84.5% 
X. laevis  24,336 27,326 89.1% 1,385 1,910 72.5% 
D. rerio 27,063 36,478 74.2% 1,883 5,115 36.8% 
D. melanogaster 24,394 54,517 44.7% 4,848 23,398 20.7% 
C. elegans 18,159 47,659 38.1% 1,167 14,832 7.9% 
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annotations for that gene were considered as candidates for rescue. An annotation was 
rescued if it was present in any other members of the reciprocal group (in a different 
organism). Non-IEA annotations were tallied separately, because they may be based upon 
the excluded organism. To examine the performance using only non-IEA annotations, 
only non-IEA annotations were considered for rescue and were only rescued if annotated 
with non-IEA evidence in a different organism. Best-match (Table 4.6A) and high-
quality reciprocal groups (Table 4.6B) were tested separately for robustness. 
In general, each organism had significantly better recovery when all annotations could be 
used for recovery, and the less stringent high-quality reciprocal groups yielded more 
rescued annotations than best-match groups. The degree of recovery was different for 
each organism, and corresponds to the degree of unique annotations for that organism. 
For example, two of the organisms with the fewest non-IEA annotations, Xenopus laevis 
and Gallus gallus, had the best recovery using non-IEA annotations. However, other 
organisms faired less well in non-IEA recovery, indicating that there isn’t yet significant 
overlap in non-automated annotation across these organisms.  
HomoloGene ortholog comparison 
It is also useful to compare the orthologs predicted by CrossGene reciprocal groups to 
those from other sources. One commonly used source is NCBI’s HomoloGene database 
(Wheeler et al. 2008). HomoloGene merges genes into clusters based upon protein 
sequence similarity and genomic synteny, which requires sequenced genomes. 
Additionally, HomoloGene includes a mechanism for directly including paralogs into 
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their clusters1. CrossGene does not actively search for paralogs, although they can be 
included in the same reciprocal group if they are connected through other organisms. 
HomoloGene clusters (release 64) were retrieved from NCBI, with each gene identified 
by an NCBI GeneID. Not all organisms present in CrossGene were present in 
HomoloGene, or in the case of Drosophila melanogaster, CrossGene was lacking 
GeneID information. For each pair of genes in a cluster, CrossGene was searched for 
transcripts with the same GeneID. If both members of a pair were present in CrossGene, 
the pair was considered a possible match. If both transcripts belong to the same best or 
high-quality reciprocal group, the pair was confirmed by CrossGene. Confirmed and 
possible matches were classified by organism pairs and the percentage of confirmed 
matches was calculated (Tables 4.8-4.10).  
Inter-organism matches compared well to HomoloGene, with between 61.2% and 85.2% 
of HomoloGene pairs corroborated by CrossGene best-match groups (Table 4.8). Using 
high-quality groups increased the matches to between 74.2% and 91.2%. 
                                                
1 http://www.ncbi.nlm.nih.gov/HomoloGene/HTML/homologene_buildproc.html 
            129
  
Table 4.8 – HomoloGene confirmation percentage  
 Best-match High-quality 
 + self - self + self - self 
H. sapiens 77.8% 79.1% 85.0% 85.8% 
M. musculus 56.4% 65.8% 70.2% 74.5% 
R. norvegicus 74.1% 83.3% 83.7% 90.4% 
G. gallus 79.5% 85.2% 86.1% 91.2% 
D. rerio 12.0% 61.2% 19.2% 74.2% 
C. elegans 11.4% 74.6% 15.5% 87.2% 
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Table 4.9 – Percentage of organism-to-organism pairs confirmed (best-match)  
 
Cel Dr Gga Hs Mm Rn 
Cel - 71.8% 79.9% 71.5% 72.0% 79.2% 
Dr - - 81.8% 72.7% 37.9% 76.5% 
Gga - - - 84.2% 84.8% 92.2% 
Hs - - - - 78.0% 84.7% 
Mm - - - - - 83.1% 
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Table 4.10 – Percentage of organism-to-organism pairs confirmed (high-quality)  
 
Cel Dr Gga Hs Mm Rn 
Cel - 91.0% 90.7% 82.3% 83.0% 89.5% 
Dr - - 92.8% 84.6% 51.3% 88.9% 
Gga - - - 88.2% 88.7% 95.6% 
Hs - - - - 83.4% 89.0% 
Mm - - - - - 90.0% 
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Discussion 
Identification and annotation 
The major goals of CrossGene are to identify orthologous genes between different 
species and to use those matches to expand the GO annotation of matched genes. 
Orthologs are determined by the reciprocal best-matches of genes between organisms. If 
two genes are reciprocal best-matches with each other, then it is reasonable to treat the 
two as orthologs, and by definition, orthologous genes are likely to have similar 
functions. Reciprocal high quality matches serve a similar purpose, and they allow the 
function of a gene to be predicted and the annotations enriched at a less stringent 
threshold. 
Reciprocal best match GO annotations can be retrieved with and without inferred 
electronic annotations (IEA). IEA annotations are computationally produced, and have 
not been reviewed by a curator. Because CrossGene itself is a form of unsupervised 
computational annotation, the user may wish to exclude other IEA annotations in 
CrossGene reciprocal group annotations. 
Sequence and algorithm choice 
When attempting to find orthologous genes, the most important choice is the type of 
sequence to use in the comparison: amino acid or nucleic acid. Protein sequences have 
the advantage of being fewer in number, but they can require a well annotated genomic 
sequence, which may not be available for all organisms. By focusing on the 
transcriptome, as represented by UniGene clusters, an incompletely sequenced organism 
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such as Xenopus laevis can be included. Additionally, gene expression microarray probes 
are frequently designed using UniGene clusters as a template. By using UniGene as the 
basis for orthology comparison, direct use in microarray analysis is easier. 
The choice of the comparison algorithm is the next most important decision in 
determining the quality of calculated orthologies. As the evolutionary distance between 
organisms increases, the variation between nucleic acid sequences also increases; 
however, because some variations in nucleic acid sequence do not affect the amino acid 
encoded, protein sequences generally have fewer variations than nucleic acid sequences. 
Also, the directionality of nucleic acid sequences in the database is not always known or 
correct. For both of these reasons, the TBLASTX algorithm was used. TBLASTX takes 
as input DNA sequences and converts them to amino acid sequences in all open reading 
frames (ORFs) in both the 5’ and 3’ directions, yielding 6 possible ORFs. 
Reciprocal group composition 
One issue with using UniGene clusters as the main source for transcript sequences is that 
due to the clustering algorithm, one can’t be sure that a single UniGene cluster represents 
a given gene. This is because UniGene clusters can include multiple splice variants for 
the same gene; as an unsupervised algorithm, there is no guarantee that multiple variants 
will converge into a single cluster. Additionally, for some organisms, such as the 
pseudotetraploid Xenopus laevis, there can be multiple (possibly degenerate) copies of a 
gene present in the genome. The issue of a gene being represented by multiple transcripts 
in the database is addressed in two ways. First, each transcript is compared to the 
sequences from the same organism using the BLASTN algorithm. While this lets one see 
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if a sequence is unique within the same organism, these results are not used in the 
creation of reciprocal groups. When creating a reciprocal group network, only inter-
species matches are followed, but there is no limit placed on the number of transcripts 
that an organism could contribute to a network. For example, the Xenopus laevis gene 
Nkx2-5 has two independent alleles in the frog genome: Xl.22859 and Xl.48440. The 
best-match reciprocal group for this gene contains both alleles because the human, 
zebrafish, and mouse Nkx2-5 genes form a reciprocal best-match with Xl.22859 and the 
rat and chicken Nkx2-5 genes form a reciprocal best-match with Xl.48440. By not 
limiting the reciprocal groups to one member per organism, both copies of this allele are 
successfully captured in the same group (Figure 4.6). CrossGene does not explicitly 
handle paralogs. Because of this, it relies on having multiple orthologs in order to add 
paralogs to a network. This may not always be successful and is one area that needs 
further development. 
This flexibility does have a potential downside; the reciprocal best-match group may 
sometimes capture a closely related gene family. For example, the reciprocal best-match 
group for the CHN1 gene also contains the CHN2 gene (Figure 4.8). The graph shows 
two separate but connected sub-graphs for the CHN1 and CHN2 genes. These genes are 
highly related and share connections through two Caenorhabditis elegans and D. 
melanoster genes: chin-1 (Cel.29497) and RhoGAP5A (Dm.4631). The human CHN1 
gene is more closely related to mouse Chn2 than to mouse Chn1, which further connects 
the two gene groups. For this gene group, the best-match and high-quality reciprocal 
groups (Figure 4.9) are largely identical, with the addition of the mouse Chn1 gene 
(Mm.476833) which only had high-quality reciprocal matches. Interestingly, the 
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transcripts annotated as human CHN2 (Hs.663145, Hs.654753, and Hs.654611) are also 
missing from both the best-match and high-quality reciprocal groups, as they formed no 
reciprocal matches to any other CHN1/CHN2 gene. The human CHN1 and CHN2 genes 
are not very similar to each other when compared using the BLASTN algorithm. The 
human CHN2 is similar to the mouse Chn2 gene (e-value 1e-113), but this value was 
below the threshold to be called a high-quality match. Even though the composition of 
the best-match and high-quality reciprocal groups for CHN1/CHN2 are almost identical, 
the high-quality group is much more interconnected. 
Another downside with the flexibility of unbounded reciprocal group assembly is that the 
number of members in a network is highly variable. The largest reciprocal best match 
group contains 97 members (Figure 4.10), and contains a variety of coagulation factors 
and proteases linked together by a small number of Caenorhabditis elegans and 
Drosophila melanogaster proteases. When the Caenorhabditis elegans genes are 
removed, the group is only split into 3 subgroups with sizes of 5, 24, and 64 with 2 
orphans (data not shown). However, when both the Caenorhabditis elegans (n=2) and 
Drosophila melanogaster (n=11) genes are removed, 13 separate subgroups are formed 
(Figure 4.11), ranging in size from 3 to 10 members, with 2 orphaned genes. In this 
extreme case, the underlying concept of blindly merging GO term annotations from the 
whole reciprocal group can break down, as it is highly unlikely that all the members of 
the group should share all annotations. However, out of 22,457 best-match groups with 
more than one member, only 270 (1.2%) have more than 20 members, so this problem 
may be restricted to a small subset of reciprocal groups. Inspection of these graphs would  
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Figure 4.8 – Reciprocal best-match group for CHN1/CHN2 
The network is separated into two distinct groups: CHN1 and CHN2. The two groups are 
bridged by the Caenorhabditis elegans and Drosophila melanogaster ancestor genes 
chin-1 (Cel.29497) and RhoGAP5A (Dm.4631), respectively (green). The groups are also 
connected via a reciprocal best-match between human CHN1 and mouse Chn2. The 
widths of the edges are inversely proportional to the e-value of the match.   
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Figure 4.9 – High-quality reciprocal group for CHN1/CHN2 
The composition of the two groups is identical to Figure 4.8, with the addition of the 
mouse Chn1 gene (Mm.476833) (yellow), which is only a reciprocal high-quality match 
for human and rat CHN1. By including edges for high-quality matches the GraphViz dot 
algorithm produces a very different graph layout, which is still largely divided into two 
distinct CHN1 and CHN2 groups that are now more interconnected. The widths of the 
edges are inversely proportional to the e-value of the match. Best matches are shown with 
solid lines, high-quality matches are shown in dashed lines.  
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Figure 4.10 – Reciprocal group 654 
Best-match group #654 contains 97 genes, consisting of mainly coagulation factors and 
proteases. The full reciprocal group is large, but it still forms a completely connected 
graph. Caenorhabditis elegans and Drosophila melanogaster genes (13) are highlighted 
in purple. When the Caenorhabditis elegans and Drosophila melanogaster genes are 
removed, 13 sub-graphs are formed (A-M), leaving 2 orphaned genes that are 
disconnected from all others (yellow).  
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Figure 4.11 – Reciprocal group 654, trimmed 
When Caenorhabditis elegans and Drosophila melanogaster genes are removed (Figure 
4.10, shown in purple) from the graph, 13 independent groups are left ranging in size 
from 3 to 10 (A-M), leaving 2 orphaned genes that are disconnected from all others 
(yellow).
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allow an investigator to focus on the most related subgroups and decide if manually 
omitting a connection would clarify the annotations. 
Reciprocal group GO annotation 
Best-match reciprocal groups provide a good estimate of orthologous genes among 
multiple organisms. This relationship is exploited to enhance the annotation of all 
members of an orthologous group. For example, Nkx2-5 is a cardiogenic transcription 
factor involved in early determination of the heart field in the developing embryo, and its 
role in embryonic and adult hearts has been well established in a variety of organisms 
(Komuro et al. 1993; Lints et al. 1993; Grow et al. 1998). However, in the UniProt GOA 
database, the Xenopus laevis Nkx2-5 gene (UniProt: P42583 and Q7T0T3) lacks the GO 
term annotation for heart development (GO:0007507). In the same database, the Mus 
musculus Nkx2-5 gene (UniProt:P42582,Q3UQU2,Q925V3) is correctly annotated with 
the GO term for heart development. In fact, Mus musculus is the only organism whose 
Nkx2-5 gene is annotated with the heart development GO term using a non-IEA evidence 
code (Figure 4.5). By using the collective annotation of the reciprocal best-match group, 
this critical annotation is now correctly applied to the Xenopus laevis Nkx2-5 gene. 
Conclusions 
The functional annotation of any one organism contains many gaps. However, when 
combined with the annotations from other organisms, those gaps can be reduced. We 
used sequence similarity between transcripts to predict orthologs. By using reciprocal 
best-match relationships, CrossGene was able to greatly augment the annotation of a 
gene, based upon the existing annotations of orthologs. The increased annotation was 
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most striking in less annotated organisms, but was substantial even in well-studied ones. 
CrossGene greatly augments the number of GO annotations even for human transcripts, 
which showed a 46% increase in average number of annotations. Additionally, the lack of 
redundancy in GO annotations argues for strategies like CrossGene in order to take full 
advantage of cross-species annotation. In providing a more complete annotation, 
CrossGene can help researchers better understand the functions of unknown genes in the 
context of genomic scale experiments.  
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CHAPTER 5: CONCLUSIONS 
Genomics and microarray technology have changed the way in which molecular biology 
is studied. We no longer only study the effect that perturbing one gene may have on 
another; rather, we can now study broad changes in expression across the entire 
transcriptome. This study aimed to exploit microarray technology to find novel targets of 
Nkx2-5 in early cardiogenesis, and in doing so, learn how to improve the use of Xenopus 
laevis as a model system by better annotating its genes. 
It was shown that over-expressing Nkx2-5 in Xenopus laevis embryos caused broad 
changes in the expression of genes involved in development. The GO annotations of 
genes that were differentially expressed were enriched for transcriptional activity and 
DNA binding (Table 2.2). Moreover, developmental genes tended to be up-regulated, 
confirming the role of Nkx2-5 as positive regulator of development (Table 2.3). Using 
the CrossGene database (Chapter 4) to map Xenopus laevis genes to Mus musculus genes, 
network analysis was performed and found that many of the affected gene networks were 
related to development and cardiogenesis (Figure 2.9, Figure 2.10, Table 2.6). Finally, 
using GO annotation and spatial gene expression patterns, a list of potential targets of 
Nkx2-5 was compiled (Table 2.7). 
Some of these potential Nkx2-5 targets were further characterized with gene expression 
profiling (Chapter 3). Initially, semi-quantitative RT-PCR was used to narrow a list of 
candidate genes for quantitative real-time PCR profiling. Two candidate genes (Hbox1 
and Zic5) that were up-regulated in the Nkx2-5 over-expression microarrays had 
expression patterns that correlated well with the pattern of Nkx2-5 (Figure 3.11, Table 
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3.6). While correlation does not necessarily mean that Nkx2-5 has a direct regulatory 
effect on Hbox1 or Zic5, both Hbox1 and Zic5 have potential NK2 and HBOX binding 
sites in their promoter regions (Table 2.7), so it is possible that Nkx2-5 does directly act 
on them to help regulate their expression. The correlated expression patterns of Nkx2-5, 
Hbox1, and Zic5 could also be indicative of a common regulatory mechanism, such as 
TGF-! signaling. 
Down-regulated candidate genes (Mix1 and Bix2) had expression profiles that showed no 
correlation with Nkx2-5 (Figure 3.11, Table 3.6). This means that direct regulation of 
these genes by Nkx2-5 is unlikely.  
The genome of Xenopus laevis has not been sequenced, and because of its allotetraploidy, 
it is not likely to be sequenced in the future. This has also hindered genetic studies to help 
annotate the Xenopus laevis genome. For GO enrichment and network analysis of the 
Nkx2-5 over-expression microarray data, improved annotation was needed. To help 
improve the annotation of Xenopus laevis, a new annotation database was constructed 
(Chapter 4). The CrossGene database was build to find orthologous genes by calculating 
reciprocal best BLAST matches between seven species: Homo sapiens, Mus musculus, 
Rattus norvegicus, Gallus gallus, Xenopus laevis, Danio rerio, Drosophila melanogaster, 
and Caenorhabditis elegans. The reciprocal best BLAST matches were then assembled 
into networks of orthologous genes. The composition of these networks compared 
favorably to HomoloGene clusters, with between 60%-90% of orthologous pairs 
maintained in CrossGene reciprocal groups. The GO annotations for each member of the 
networks were then applied to all of the other members, to enhance the annotation of the 
entire network.  
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Even well-studied organisms, such as human, benefitted from cross-species annotation, 
resulting in 46% more annotations per gene (Table 4.5). For less well annotated 
organisms, in particular Xenopus laevis, annotation was greatly enriched, with 280% 
more annotations per gene.  
The robustness of existing GO annotations was tested by attempting to “rescue” all 
previously known annotations of an organism using CrossGene reciprocal group 
annotations (Table 4.6, Table 4.7). Robustness of a GO annotation term is a measure of 
how many organisms are annotated with that term within in an ortholog group. If an 
annotation appears in more than one organism, it is robust and could be “rescued” using 
the annotations of the other members of the ortholog group. If a term only appears in one 
organism, it cannot be “rescued” and is not robust. For all organisms, existing GO 
annotations lacked robustness, especially when the rescue required the more stringent 
non-IEA (non-computational) GO annotations. This illustrates that even for well-studied 
organisms, there are still gaps and missing associations in the primary GO annotation 
databases. This emphasizes the need for computational forms of annotation, such as 
CrossGene, to provide a more complete picture of a gene’s function. 
A concrete example of this problem is Nkx2-5. Nkx2-5 is annotated as having a role in 
heart development (GO:0007507) only in mouse. For human, rat, and chicken, this 
annotation is only covered using non-experimental or IEA (computationally derived 
annotation) evidence. The role of Nkx2-5 in heart development is a well-known activity 
that is supported by the literature in multiple organisms, but is not annotated as such in 
the EBI Gene Ontology Annotation database (Camon et al. 2004b). If a researcher were 
to use only non-IEA annotations in their analysis, this well-known function of Nkx2-5 
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would be missed. This argues strongly for using methods, like CrossGene, that combine 
known annotations from multiple organisms for a more thorough functional annotation. It 
also emphasizes the need for including IEA GO annotation evidence in downstream 
analysis. 
After the Nkx2-5 microarray experiment was completed, candidate genes for RT-PCR 
and qPCR expression profiling were selected after the first version of the CrossGene 
database was completed. It wasn’t until after expression profiling was completed that the 
CrossGene database took its current form and the more thorough analysis of changes in 
expression (Chapter 2) was possible. The order in which the work was completed was a 
necessary evil, and it made the analysis less cohesive. One example of this is that the 
potential targets identified in Chapter 2 after CrossGene was completed were not 
necessarily the same as those that were profiled (Chapter 3). While there was a good 
rationale behind choosing the genes that were profiled, it is clear from the analysis in 
Chapter 2 that certain obvious choices were excluded in these profiles. Additionally, 
there was one gene that was initially selected for qPCR profiling that didn’t make the list 
of 99 putative targets in Chapter 2 (Tie2). Also, several of the potential targets in Chapter 
2 would have made more compelling candidates for profiling, such as Twist and Pax3. 
However, this is a risk whenever data are re-analyzed using updated information. 
One of the interesting results was the combination of Nkx2-5 and NF-!B in an Ingenuity 
derived network (Figure 2.9). NF-!B is a protein complex that has a significant role in 
the inflammatory response (Sen et al. 1986; Barnes et al. 1997) and apoptosis (Barkett et 
al. 1999). Controlled cell death, through apoptosis, is an important part of an organism’s 
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development (Meier et al. 2000), but this only occurs much later in development when it 
is necessary for the organism to remove extraneous tissue. NF-!B is also known to have a 
role in mediating the adult response to myocardial diseases, but this doesn’t necessarily 
extend to the developing heart (Haudek et al. 2001; Carlson et al. 2003). While NF-!B 
has no known role in cardiovascular development (Oka et al. 2007), it is possible that 
Nkx2-5 and NF-!B could indirectly interact through the TGF-! signaling pathway 
(Bitzer et al. 2000). Since the expression of Nkx2-5 is partially driven through the TGF-! 
pathway, it is possible that there is some amount of crosstalk between the two pathways 
through common SMAD factors. Another possible link between the two is through 
Meox1 and Meox2 (Figure 2.9). Like Nkx2-5, Meox1 and Meox2 are both homeodomain 
transcription factors that are involved in myogenesis (Petropoulos et al. 2004). 
Additionally, Meox2 is involved in the development of cardiomyocytes in mouse 
embryos (Skopicki et al. 1997) and has been shown to interact with NF-!B to inhibit 
angiogenesis (Patel et al. 2005). Additionally, Meox1 and Meox2 have also been known 
to associate with Pax3 (Stamataki et al. 2001), which was one of the predicted Nkx2-5 
targets that matched all three of the prioritization criteria in Chapter 2. Evidence for a link 
between Nkx2-5 and NF-!B is weak, but it does underscore the potential for crosstalk 
between different signaling pathways in early development. 
One explanation for the broad set of changes in genes related to development (Chapter 2) 
is that by injecting Nkx2-5 RNA, the timing of development was accelerated. 
Development is a complex series of events that are well coordinated. Any changes in that 
timing could have profound effects on many different pathways and genes. This could be 
accomplished through changes in the expression of common developmental regulators, 
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such as BMP or sonic hedgehog (Shh) signaling. Both of these genes were up-regulated 
in response to Nkx2-5 overexpression. Like the potential NF-!B interactions, this would 
not need to be through a direct interaction, but could be the result of molecular cross-talk 
between pathways. When measured against a control at a single time point, any 
acceleration in development timing would be seen as a broad up-regulation of 
developmentally related genes. This is one possible interpretation of the GO enrichment 
analysis in Chapter 2 and is one potential mechanism by which a tissue specific 
transcription factor, such as Nkx2-5, could have had such a large effect on so many 
developmental genes.  
One method to test this possibility would be to re-examine the changes in gene 
expression caused by Nkx2-5 overexpression using a series of time points. Again using 
microarrays, multiple development stages could be used for gene expression profiling. 
This way, any changes in the expression patterns of genes could be compared not only in 
terms of scale (up or down regulated) but also in terms of timing. In this case, changes in 
the expression pattern of a gene would be far more informative than expression level 
differences at any single time point.  
Future studies should also focus on confirmation of the targets predicted in Chapter 2. 
This could be done using a variety of techniques. A low-throughput technique would be 
ChIP assay. This technique involves using an immunoprecipitation to pull down a protein 
bound to DNA/chromatin. Next, using targeted primers, PCR is used to confirm that a 
protein was in fact bound to a specific promoter. The prospect of this type of assay in the 
future was the reason for using Nkx2-5 tagged with an HA epitope. Unfortunately, a 
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ChIP assay requires knowing the DNA sequence of the promoter for the targeted gene, so 
that PCR primers can be properly designed to amplify the bound region. It is not known 
if the Xenopus tropicalis genome sequence is similar enough to Xenopus laevis genome 
to conduct this experiment in Xenopus laevis. A high-throughput approach would be a 
ChIP-seq assay, which starts with the same immunoprecipitation, but instead of using 
promoter specific PCR primers, all genomic positions where Nkx2-5 was bound are be 
determined using next-generation sequencing. In this case, it would be easier to use the 
Xenopus tropicalis genome as a surrogate for Xenopus laevis, but there may still be other 
issues mapping next-generation sequencing reads from Xenopus laevis to the Xenopus 
tropicalis genome. While it is possible to for Xenopus tropicalis mRNA to hybridize to a 
Xenopus laevis cDNA microarray (Figure 1.3), it isn’t known how homologous their 
promoters are. Because promoter regions aren’t under as much pressure to be conserved 
evolutionarily, they can be more divergent than protein coding genes, which would make 
mapping more difficult. Additionally, because of the allotetraploid nature of the Xenopus 
laevis genome, multiple loci from the Xenopus laevis genome could map to a single 
position on the Xenopus tropicalis genome. This would make data processing much more 
difficult. 
Because of the difficulty in dealing with the limitations of the unsequenced Xenopus 
laevis genome, I believe that any further follow-up confirmation may be better suited to 
be performed in a different model system. The murine P19CL6 cardiomyocyte induction 
cell line (Chapter 1) or Xenopus tropicalis would be good systems for this. If these results 
in the P19CL6 cell induction model could be reliably replicated, this would be my 
preferred system for follow-up work, due to the extensive annotation of the mouse 
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genome and maturity of the assembled mouse genomic sequence. Additionally, at this 
point, the P19CL6 cardiomyocyte induction model is the most common system for 
studying cardiomyogenesis. At this point in time, the state of Xenopus tropicalis genomic 
sequence is still quite immature, and so mouse would be my preferred model. Switching 
to the P19CL6 induction model would be a big change, so in this case, the microarray 
experiment presented here should be replicated in that system. 
In addition to updating the database with new UniGene builds, future work on the 
CrossGene database should attempt to resolve the issue of properly annotating 
excessively large reciprocal networks. One method would be to simply break apart 
excessively large networks into smaller sub-networks by removing nodes that have a high 
“betweenness centrality” (Freeman 1977). This is a measure of how important a 
particular node is in linking the various parts of a graph. In CrossGene reciprocal group 
networks, ancestor genes that link multiple sub-networks have a high betweenness 
centrality. If these were simply removed from the larger networks, or made to be 
members of all of the sub-networks without linking the sub-networks, this could reduce 
the problem of overly large networks and over annotation they cause. 
Greater insight into the molecular signaling in early cardiogenesis would increase our 
understanding of the mechanisms behind many congenital heart diseases. This in turn 
could enable further treatment options. Additionally, characterizing the signaling 
pathways that drive differentiation of pluripotent cells into cardiomyocytes could aide in 
the development of therapeutic treatment options for adults suffering from heart disease 
or who have had myocardial infarction. The potential targets identified in this study 
represent a solid first step in that direction.  
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APPENDIX 1: PCR PRIMERS 
Table A1.1 – Primer3 design parameters 
Primers were designed with Primer3 software using these parameters (Rozen et al. 2000). 
Parameter  Value 
Optimal size 24 bp 
Minimum size 22 bp 
Maximum size 25 bp 
GC Clamp No 
Optimal Tm 60 
Minimum Tm 58 
Maximum Tm 64 
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Table A1.2 – Primer sequences used in this study 
Target/reference Sequence (Forward/Reverse) Product size 
(bp) 
Injection confirmation 
ODC-RT ATCGTATCGTAGAAAGGTTTGAGC 
AGATCTGGTACTTCAGGGAGAATG 
294 
Nkx2-5HA CTTACAATTCCCCATACAATGTCA 
TGGTAACCAGATCCTAGTCAGTCA 
283 
Nkx2-5-RT AGATGTCTACTGAAGCACTGATGC 
GTTATCATTTTGATCAGGGAAACC 
281 
Semi-quantitative RT-PCR profiling 
AFFX-Xl-a1Act-
3_s_at 
GAGAGGTATCCTGACCCTGAAGTA 
TATATGTTGCTTGGAGGAGTGTGT 
977 
AFFX-Xl-bAct-
5_s_at 
GCCAATATATGAAGGCTATGCTCT 
TCCAGACAGAGTATTTACGCTCAG 
533 
Xl.580.1.S1_at AAAACTGAACCGGTAAAACTTGAG 
CCATTTATTTCTGGTGGTGTCATA 
626 
Xl.6393.1.S1_at AAGATCCTTCAGGCATTATTTCAG 
CCCACATCTGTCACATATTTCATT 
632 
Xl.793.1.A1_at CATGAGGAGAAGGAATGTGTAGTG 
ACTTGCTAGACATTTTTCGGTTTC 
580 
Xl.824.1.S1_at AAACCAGAGGTGTATTCTACCAGC 
TTTTGTGTCTGAACCATTGTCTTT 
677 
Xl.481.1.S1_at GGGAAGATACCATTATGACACACA 
TGTTGATATAGGCAACCAGTGAGT 
575 
Xl.975.1.S1_at ATATTTTTCCTAGGCCTTCTGCTT 
GTGCAGAACTGAGATATTTGGATG 
756 
Xl.397.1.S1_at CTTCTCCTCCAGTGACCATCTAAT 
CACATAGTTCTCCCTCAATCTCCT 
878 
Xl.18750.1.S1_at GTATCCAAACCCAGAATCCACTAC 
ACAATGTTCTCCATCTTCCTCTTC 
900 
Xl.1685.1.S1_at GACAGTTCTCAAATCCCTGTTCTT 
ACTTTAGCATACACCTCCGCTATC 
544 
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Table A1.2 (continued) 
Target/reference Sequence (Forward/Reverse) Product size 
(bp) 
Xl.21901.1.S1_at CCGTATTCTTGTGGACTTACACTG 
AGATTCAAACGTCATTCTCAAACA 
639 
Xl.866.1.S2_at TCATTTATACAGCAGATCCCAAGA 
ATATAATTTATTGAACCTCGCCCA 
1008 
Xl.12160.1.S1_at GAAAAGACTGAAAGTGCAACTCAA 
AAATATCTCAACTTCTGGTCTGCC 
541 
Xl.1093.1.S1_at CTTACAATTCCCCATACAATGTCA 
AACTGGCAGTATAAGGCACATACA 
1057 
Xl.16169.1.S1_at CATGTGAATGTGGCATTTTTATTT 
TATACACAAGCTTAGCGCTGTTTC 
800 
Xl.823.1.S1_at AGAGAAGGAGGCTCAGTAAAGTCA 
TATATAAAGGAGCATCTGGCACAA 
943 
Xl.1043.1.S1_at ACAAAAGAAGTTAAAGAGCGCCTA 
TTTAGAGCAGGGCTTTTTAGAAGA 
884 
Xl.933.1.S1_at AAGTATGTCAATGGAGAATGGGTT 
AAGAGAAGTTGAGCTCCGAAGATA 
846 
Xl.8190.1.S1_at AAGCCATCATTATTCTAGCACCTC 
AAACATTCTCTTCCCAGTCTGAAC 
605 
Xl.146.1.S1_at AAGAGATTTCCTGAAACCTGATTG 
TATAACACATGGTAGATTGGTCGG 
833 
Xl.13437.1.A1_at GGAAGGTCATTCAATCTCTTCTGT 
ATATTTCTTGCTGCTAAATCCCTG 
924 
Xl.1394.1.S1_at GATGATGAGACAGCCATTAATCAG 
TTATCATGTATTTTTAGAGCGCCA 
863 
Xl.1209.1.S1_at GAGAGAGACAGAGAGAGAGCCAGT 
AGGAATAACGCAGAGACTGAGAGT 
903 
Xl.8333.1.A1_at AGTCCATGTCTTTGTGACAGTGTT 
GTATTTGACTCCAGCAGAGCACTA 
637 
Xl.25598.1.S1_at ATGGGTTTGGATCGTATAAAAGAA 
AAGTGTCTCACCAACATTACTCCA 
565 
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Table A1.2 (continued) 
Target/reference Sequence (Forward/Reverse) Product size 
(bp) 
Xl.25289.1.A1_at TTCATTACTTGGAGTCAGAATGGA 
TGAGAAATAACGCCACTTTCATTA 
1004 
Xl.16644.1.S1_at ATCCCTTTTAAAGAGTACCAAGGG 
AGTGTTTAACAGGAAAGTTGGGAG 
803 
Xl.15793.1.A1_at CAGAGATAGCTACAGCCAACTGAA 
CTGTATGATTGCGTAGTTTCCATC 
682 
 Xl.15970.1.A1_at TATGGATACTGAGGCAAAGAATCA 
ATGAACCCATCATTAAGGACACTT 
780 
Xl.9113.1.A1_at AAGTTTACAGTTGTGACCTGACCA 
CATCTCACAAATGATTTCTTCCTG 
618 
Xl.19790.1.S1_at GGAATCAGACAGCTACAAGCTACA 
GATGCTTTCATTGATGCTCATTAC 
624 
Xl.20765.1.A1_at ATATTAATACCCAGCAGAGCTTCG 
CATCCTCTATTAGGGACTGCTGAT 
645 
Xl.13885.1.A1_s_at AATGGGACCTGACTAAACAAAGAG 
AATTGTTGTGGAAAGAGCACATTA 
588 
!-actin GCACCAGAAGAACACCCAGT 
CTGGAAGAGTGCCTCTGGAC 
500 
Real-time qPCR 
Nkx2-5-rt GCTCTCCTTTGAAAAGCCCT 
GCCTGGAAGTGATGTCCATT 
196 
Bix2-rt AGGAACTGGCCAGACAAATG 
TGCTATGGTGATTGTGCCAT 
182 
CHN1-rt CTCCAGATCCTGATGCACAA 
GTTGGGCCGAACACTATACC 
169 
HBox1-rt TAGCTGCAGGCAGAACTCAA 
CCAGAGTTTGGTAACGGGAA 
209 
Mix1-Xanthos 
(Xanthos et al. 2001) 
GCAGATGCCAGTTCAGCCAATG 
TTTGTCCATAGGTTCCGCCCTG 
188 
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Table A1.2 (continued) 
Target/reference Sequence (Forward/Reverse) Product size 
(bp) 
Zic5-rt 
 
TGGGAGTATGGGCTATCCTG 
CATATTAACGGTTGCCCCTG 
157 
ODC-Heasman 
(Heasman et al. 2000) 
GCCATTGTGAAGACTCTCTCCATTC 
TTCGGGTGATTCCTTGCCAC 
221 
GAPDH-rt CTTTGATGCTGATGCTGGAA 
GACAGACTAGCAGGATGGGC 
195 
Miscellaneous primers 
M13 Forward TGTAAAACGACGGCCAGT - 
M13 Reverse CAGGAAACAGCTATGACC - 
Anchored oligo-dT TTTTTTTTTTTTTTTTTTTV - 
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APPENDIX 2: GO ENRICHMENT IN NKX2-5 OVEREXPRESSION 
MICROARRAYS 
Table A2.1 – Biological Process – up-regulated genes 
GO Name Expected Actual Fisher   
p-value 
GO:0003002 regionalization 11 31 5.5E-08 
GO:0007389 pattern specification process 15 37 9.7E-08 
GO:0035282 segmentation 4 16 1.3E-07 
GO:0030154 cell differentiation 27 53 2.6E-07 
GO:0009952 anterior/posterior pattern formation 6 21 3.7E-07 
GO:0032501 multicellular organismal process 55 87 4.5E-07 
GO:0045893 positive regulation of transcription, DNA-
dependent 
13 31 8.5E-07 
GO:0010557 positive regulation of macromolecule 
biosynthetic process 
16 36 9.1E-07 
GO:0051254 positive regulation of RNA metabolic process 13 31 9.4E-07 
GO:0009887 organ morphogenesis 15 35 1.2E-06 
GO:0001756 somitogenesis 3 12 1.6E-06 
GO:0048598 embryonic morphogenesis 13 30 2.5E-06 
GO:0045944 positive regulation of transcription from RNA 
polymerase II promoter 
10 26 2.5E-06 
GO:0007275 multicellular organismal development 30 54 2.8E-06 
GO:0031328 positive regulation of cellular biosynthetic 
process 
16 36 2.9E-06 
GO:0009891 positive regulation of biosynthetic process 17 36 3.1E-06 
GO:0048731 system development 19 39 4.0E-06 
GO:0009893 positive regulation of metabolic process 20 40 8.2E-06 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0048646 anatomical structure formation involved in 
morphogenesis 
13 30 8.8E-06 
GO:0010604 positive regulation of macromolecule 
metabolic process 
19 39 9.4E-06 
GO:0007494 midgut development 2 8 1.0E-05 
GO:0048705 skeletal system morphogenesis 3 11 1.1E-05 
GO:0031325 positive regulation of cellular metabolic 
process 
20 39 1.1E-05 
GO:0045935 positive regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 
15 33 1.2E-05 
GO:0048704 embryonic skeletal system morphogenesis 2 9 1.3E-05 
GO:0007366 periodic partitioning by pair rule gene 1 4 2.1E-05 
GO:0045941 positive regulation of transcription 14 31 2.1E-05 
GO:0048869 cellular developmental process 37 61 2.2E-05 
GO:0010628 positive regulation of gene expression 14 31 2.2E-05 
GO:0021570 rhombomere 4 development 1 3 2.2E-05 
GO:0001709 cell fate determination 4 13 3.4E-05 
GO:0006357 regulation of transcription from RNA 
polymerase II promoter 
17 33 4.8E-05 
GO:0001501 skeletal system development 5 15 5.7E-05 
GO:0009880 embryonic pattern specification 5 15 7.5E-05 
GO:0048706 embryonic skeletal system development 2 7 1.3E-04 
GO:0030902 hindbrain development 2 8 1.4E-04 
GO:0035239 tube morphogenesis 5 13 1.7E-04 
GO:0008045 motor axon guidance 2 7 1.8E-04 
GO:0048532 anatomical structure arrangement 1 3 2.2E-04 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0021612 facial nerve structural organization 1 3 2.2E-04 
GO:0021604 cranial nerve structural organization 1 3 2.2E-04 
GO:0021561 facial nerve development 1 3 2.2E-04 
GO:0048565 gut development 3 9 2.4E-04 
GO:0048741 skeletal muscle fiber development 1 5 2.4E-04 
GO:0030539 male genitalia development 1 5 2.4E-04 
GO:0048747 muscle fiber development 1 6 3.3E-04 
GO:0021545 cranial nerve development 1 4 3.7E-04 
GO:0021569 rhombomere 3 development 1 3 4.2E-04 
GO:0048732 gland development 4 12 4.5E-04 
GO:0048856 anatomical structure development 53 74 4.7E-04 
GO:0002076 osteoblast development 1 4 5.0E-04 
GO:0007365 periodic partitioning 2 7 5.3E-04 
GO:0001570 vasculogenesis 2 7 5.3E-04 
GO:0021953 central nervous system neuron differentiation 1 4 6.7E-04 
GO:0051658 maintenance of nucleus location 1 2 8.0E-04 
GO:0051594 detection of glucose 1 2 8.0E-04 
GO:0045721 negative regulation of gluconeogenesis 1 2 8.0E-04 
GO:0042070 maintenance of oocyte nucleus location 
involved in oocyte dorsal/ventral axis 
specification 
1 2 8.0E-04 
GO:0034287 detection of monosaccharide stimulus 1 2 8.0E-04 
GO:0010359 regulation of anion channel activity 1 2 8.0E-04 
GO:0009732 detection of hexose stimulus 1 2 8.0E-04 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0009730 detection of carbohydrate stimulus 1 2 8.0E-04 
GO:0055001 muscle cell development 1 5 8.5E-04 
GO:0045740 positive regulation of DNA replication 1 5 8.5E-04 
GO:0060606 tube closure 1 5 1.0E-03 
GO:0001843 neural tube closure 1 5 1.0E-03 
GO:0051603 proteolysis involved in cellular protein 
catabolic process 
10 1 1.0E-03 
GO:0044257 cellular protein catabolic process 10 1 1.0E-03 
GO:0034962 cellular biopolymer catabolic process 10 1 1.0E-03 
GO:0030198 extracellular matrix organization 3 8 1.1E-03 
GO:0035287 head segmentation 1 4 1.1E-03 
GO:0021675 nerve development 1 4 1.1E-03 
GO:0009267 cellular response to starvation 1 4 1.1E-03 
GO:0021754 facial nucleus development 1 3 1.1E-03 
GO:0022610 biological adhesion 11 21 1.3E-03 
GO:0007155 cell adhesion 11 21 1.3E-03 
GO:0007399 nervous system development 11 21 1.4E-03 
GO:0055002 striated muscle cell development 1 4 1.4E-03 
GO:0060537 muscle tissue development 3 8 1.4E-03 
GO:0043632 modification-dependent macromolecule 
catabolic process 
9 1 1.5E-03 
GO:0019941 modification-dependent protein catabolic 
process 
9 1 1.5E-03 
GO:0045165 cell fate commitment 6 14 1.6E-03 
GO:0048522 positive regulation of cellular process 36 53 1.6E-03 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0048857 neural nucleus development 1 3 1.7E-03 
GO:0045821 positive regulation of glycolysis 1 3 1.7E-03 
GO:0042063 gliogenesis 1 3 1.7E-03 
GO:0021571 rhombomere 5 development 1 3 1.7E-03 
GO:0048663 neuron fate commitment 3 8 1.8E-03 
GO:0009888 tissue development 12 23 2.0E-03 
GO:0034621 cellular macromolecular complex subunit 
organization 
9 1 2.3E-03 
GO:0043374 CD8-positive, alpha-beta T cell differentiation 1 2 2.4E-03 
GO:0043282 pharyngeal muscle development 1 2 2.4E-03 
GO:0033604 negative regulation of catecholamine 
secretion 
1 2 2.4E-03 
GO:0032811 negative regulation of epinephrine secretion 1 2 2.4E-03 
GO:0014060 regulation of epinephrine secretion 1 2 2.4E-03 
GO:0001823 mesonephros development 1 2 2.4E-03 
GO:0044267 cellular protein metabolic process 43 26 2.5E-03 
GO:0007350 blastoderm segmentation 1 4 2.6E-03 
GO:0050794 regulation of cellular process 95 115 2.6E-03 
GO:0050877 neurological system process 13 24 2.7E-03 
GO:0035148 tube lumen formation 1 5 2.8E-03 
GO:0000904 cell morphogenesis involved in differentiation 3 8 2.9E-03 
GO:0048513 organ development 39 55 2.9E-03 
GO:0003008 system process 18 30 3.0E-03 
GO:0048754 branching morphogenesis of a tube 4 9 3.0E-03 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0014029 neural crest formation 1 3 3.1E-03 
GO:0042552 myelination 2 5 3.2E-03 
GO:0007379 segment specification 2 5 3.2E-03 
GO:0006275 regulation of DNA replication 2 7 3.2E-03 
GO:0050890 cognition 12 22 3.3E-03 
GO:0001658 branching involved in ureteric bud 
morphogenesis 
1 4 3.6E-03 
GO:0042475 odontogenesis of dentine-containing tooth 2 6 3.6E-03 
GO:0007600 sensory perception 9 18 3.8E-03 
GO:0014706 striated muscle tissue development 3 7 3.8E-03 
GO:0035290 trunk segmentation 1 3 4.1E-03 
GO:0030199 collagen fibril organization 1 3 4.1E-03 
GO:0010556 regulation of macromolecule biosynthetic 
process 
44 60 4.5E-03 
GO:0060395 SMAD protein signal transduction 1 2 4.6E-03 
GO:0051657 maintenance of organelle location 1 2 4.6E-03 
GO:0051365 cellular response to potassium ion starvation 1 2 4.6E-03 
GO:0051156 glucose 6-phosphate metabolic process 1 2 4.6E-03 
GO:0045084 positive regulation of interleukin-12 
biosynthetic process 
1 2 4.6E-03 
GO:0045075 regulation of interleukin-12 biosynthetic 
process 
1 2 4.6E-03 
GO:0048066 pigmentation during development 2 6 4.8E-03 
GO:0008284 positive regulation of cell proliferation 8 16 4.8E-03 
GO:0034622 cellular macromolecular complex assembly 8 1 4.8E-03 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0043933 macromolecular complex subunit 
organization 
16 6 4.9E-03 
GO:0046632 alpha-beta T cell differentiation 1 3 5.2E-03 
GO:0035289 posterior head segmentation 1 3 5.2E-03 
GO:0045595 regulation of cell differentiation 15 26 5.3E-03 
GO:0006355 regulation of transcription, DNA-dependent 35 50 5.4E-03 
GO:0048468 cell development 12 22 5.5E-03 
GO:0060021 palate development 1 4 5.7E-03 
GO:0031669 cellular response to nutrient levels 1 4 5.7E-03 
GO:0002763 positive regulation of myeloid leukocyte 
differentiation 
1 4 5.7E-03 
GO:0051276 chromosome organization 10 2 6.2E-03 
GO:0006576 biogenic amine metabolic process 2 6 6.2E-03 
GO:0051252 regulation of RNA metabolic process 37 52 6.3E-03 
GO:0001822 kidney development 3 8 6.4E-03 
GO:0030097 hemopoiesis 4 9 6.5E-03 
GO:0030947 regulation of vascular endothelial growth 
factor receptor signaling pathway 
1 3 6.5E-03 
GO:0021546 rhombomere development 1 3 6.5E-03 
GO:0006110 regulation of glycolysis 1 3 6.5E-03 
GO:0019538 protein metabolic process 49 33 6.5E-03 
GO:0016337 cell-cell adhesion 5 10 6.6E-03 
GO:0031326 regulation of cellular biosynthetic process 45 61 6.6E-03 
GO:0042594 response to starvation 1 4 6.6E-03 
GO:0018958 phenol metabolic process 1 4 6.6E-03 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0006584 catecholamine metabolic process 1 4 6.6E-03 
GO:0001656 metanephros development 1 4 6.6E-03 
GO:0009889 regulation of biosynthetic process 45 61 6.8E-03 
GO:0031668 cellular response to extracellular stimulus 2 5 7.0E-03 
GO:0008366 axon ensheathment 2 5 7.0E-03 
GO:0007272 ensheathment of neurons 2 5 7.0E-03 
GO:0042127 regulation of cell proliferation 16 27 7.0E-03 
GO:0042476 odontogenesis 2 6 7.3E-03 
GO:0045657 positive regulation of monocyte 
differentiation 
1 2 7.6E-03 
GO:0045655 regulation of monocyte differentiation 1 2 7.6E-03 
GO:0042415 norepinephrine metabolic process 1 2 7.6E-03 
GO:0032288 myelin assembly 1 2 7.6E-03 
GO:0008359 regulation of bicoid mRNA localization 1 2 7.6E-03 
GO:0006003 fructose 2,6-bisphosphate metabolic process 1 2 7.6E-03 
GO:0001763 morphogenesis of a branching structure 4 9 7.6E-03 
GO:0006996 organelle organization 33 19 7.7E-03 
GO:0007565 female pregnancy 2 5 7.7E-03 
GO:0003007 heart morphogenesis 3 7 7.8E-03 
GO:0046529 imaginal disc fusion, thorax closure 1 3 7.9E-03 
GO:0045596 negative regulation of cell differentiation 7 14 7.9E-03 
GO:0006928 cell motion 17 27 7.9E-03 
GO:0030217 T cell differentiation 2 5 8.5E-03 
GO:0016202 regulation of striated muscle development 2 6 8.5E-03 
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Table A2.1 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0008283 cell proliferation 12 21 9.2E-03 
GO:0048771 tissue remodeling 2 5 9.3E-03 
GO:0048660 regulation of smooth muscle cell proliferation 2 5 9.3E-03 
GO:0046631 alpha-beta T cell activation 1 3 9.6E-03 
GO:0018210 peptidyl-threonine modification 1 3 9.6E-03 
GO:0008103 oocyte microtubule cytoskeleton polarization 1 3 9.6E-03 
GO:0010810 regulation of cell-substrate adhesion 1 4 9.7E-03 
GO:0006396 RNA processing 13 4 9.7E-03 
GO:0050953 sensory perception of light stimulus 5 10 1.0E-02 
GO:0007601 visual perception 5 10 1.0E-02 
GO:0009612 response to mechanical stimulus 3 7 1.0E-02 
GO:0045639 positive regulation of myeloid cell 
differentiation 
2 5 1.0E-02 
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Table A2.2 – Biological Process – down-regulated genes 
GO Name Expected Actual Fisher   
p-value 
GO:0048518 positive regulation of biological process 56 31 2.6E-05 
GO:0040008 regulation of growth 33 14 9.5E-05 
GO:0009653 anatomical structure morphogenesis 38 18 1.0E-04 
GO:0016254 preassembly of GPI anchor in ER membrane 1 4 1.2E-04 
GO:0045927 positive regulation of growth 28 11 1.3E-04 
GO:0040009 regulation of growth rate 25 9 2.1E-04 
GO:0040010 positive regulation of growth rate 25 9 2.2E-04 
GO:0002119 nematode larval development 26 10 2.8E-04 
GO:0008152 metabolic process 104 82 5.6E-04 
GO:0032502 developmental process 87 65 6.6E-04 
GO:0002164 larval development 26 11 6.8E-04 
GO:0050896 response to stimulus 49 30 9.6E-04 
GO:0044238 primary metabolic process 96 75 1.4E-03 
GO:0042592 homeostatic process 13 3 1.6E-03 
GO:0006357 regulation of transcription from RNA 
polymerase II promoter 
15 4 1.8E-03 
GO:0043170 macromolecule metabolic process 82 62 2.0E-03 
GO:0044249 cellular biosynthetic process 45 28 2.5E-03 
GO:0032268 regulation of cellular protein metabolic process 11 2 2.9E-03 
GO:0046489 phosphoinositide biosynthetic process 1 4 2.9E-03 
GO:0000003 reproduction 24 11 3.2E-03 
GO:0051246 regulation of protein metabolic process 12 3 3.3E-03 
GO:0045595 regulation of cell differentiation 14 4 3.5E-03 
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Table A2.2 (continued) 
GO Name Expected Actual Fisher   
p-value 
GO:0065008 regulation of biological quality 25 12 3.8E-03 
GO:0006506 GPI anchor biosynthetic process 1 3 3.9E-03 
GO:0006505 GPI anchor metabolic process 1 3 3.9E-03 
GO:0009058 biosynthetic process 48 31 5.0E-03 
GO:0043283 biopolymer metabolic process 80 62 5.7E-03 
GO:0042221 response to chemical stimulus 26 13 5.9E-03 
GO:0051239 regulation of multicellular organismal process 28 15 5.9E-03 
GO:0065007 biological regulation 109 91 6.0E-03 
GO:0048519 negative regulation of biological process 38 23 6.1E-03 
GO:0030325 adrenal gland development 1 2 6.2E-03 
GO:0007610 behavior 14 5 6.8E-03 
GO:0050789 regulation of biological process 104 87 7.1E-03 
GO:0007049 cell cycle 13 23 7.2E-03 
GO:0048513 organ development 35 21 8.5E-03 
GO:0040007 growth 26 14 8.9E-03 
GO:0006139 nucleobase, nucleoside, nucleotide and nucleic 
acid metabolic process 
49 33 9.0E-03 
GO:0080090 regulation of primary metabolic process 48 33 9.0E-03 
GO:0017015 regulation of transforming growth factor beta 
receptor signaling pathway 
2 6 9.3E-03 
GO:0009059 macromolecule biosynthetic process 37 23 1.0E-02 
GO:0009791 post-embryonic development 27 15 1.0E-02 
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Table A2.3 – Molecular Function – up-regulated genes 
GO  Name Expected Actual Fisher   
p-value 
GO:0003700 transcription factor activity 17 33 1.6E-04 
GO:0043565 sequence-specific DNA binding 13 26 5.8E-04 
GO:0003705 RNA polymerase II transcription factor 
activity, enhancer binding 
2 7 7.1E-04 
GO:0004396 hexokinase activity 1 2 8.1E-04 
GO:0004340 glucokinase activity 1 2 8.1E-04 
GO:0005100 Rho GTPase activator activity 1 4 9.0E-04 
GO:0016563 transcription activator activity 11 21 2.1E-03 
GO:0030528 transcription regulator activity 28 43 2.3E-03 
GO:0003677 DNA binding 33 49 3.4E-03 
GO:0003702 RNA polymerase II transcription factor 
activity 
7 15 3.5E-03 
GO:0046982 protein heterodimerization activity 6 13 4.3E-03 
GO:0005099 Ras GTPase activator activity 2 5 6.5E-03 
GO:0043138 3'-5' DNA helicase activity 1 3 8.1E-03 
GO:0003723 RNA binding 16 6 9.4E-03 
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Table A2.4 – Molecular Function – down-regulated genes 
GO  Name Expected Actual Fisher   
p-value 
GO:0004587 ornithine-oxo-acid transaminase activity 1 2 6.5E-04 
GO:0003992 N2-acetyl-L-ornithine:2-oxoglutarate 5-
aminotransferase activity 
1 2 6.5E-04 
GO:0030695 GTPase regulator activity 5 12 6.7E-04 
GO:0060589 nucleoside-triphosphatase regulator activity 5 12 1.0E-03 
GO:0017176 phosphatidylinositol N-
acetylglucosaminyltransferase activity 
1 2 1.9E-03 
GO:0004137 deoxycytidine kinase activity 1 2 1.9E-03 
GO:0005083 small GTPase regulator activity 3 9 2.8E-03 
GO:0005198 structural molecule activity 11 2 2.9E-03 
GO:0019957 C-C chemokine binding 1 2 3.8E-03 
GO:0016494 C-X-C chemokine receptor activity 1 2 3.8E-03 
GO:0016493 C-C chemokine receptor activity 1 2 3.8E-03 
GO:0005089 Rho guanyl-nucleotide exchange factor 
activity 
1 4 4.0E-03 
GO:0019958 C-X-C chemokine binding 1 2 6.2E-03 
GO:0019136 deoxynucleoside kinase activity 1 2 6.2E-03 
GO:0004950 chemokine receptor activity 1 2 6.2E-03 
GO:0001637 G-protein chemoattractant receptor activity 1 2 6.2E-03 
GO:0003723 RNA binding 14 5 9.5E-03 
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Table A2.5 – Cellular Component – up-regulated genes 
GO  Name Expected Actual Fisher   
p-value 
GO:0030529 ribonucleoprotein complex 13 1 6.6E-05 
GO:0005576 extracellular region 17 34 7.4E-05 
GO:0043218 compact myelin 1 3 4.3E-04 
GO:0005622 intracellular 24 10 1.1E-03 
GO:0043226 organelle 132 112 1.9E-03 
GO:0044421 extracellular region part 12 23 2.0E-03 
GO:0005615 extracellular space 10 20 2.5E-03 
GO:0043229 intracellular organelle 132 112 2.6E-03 
GO:0043232 intracellular non-membrane-bounded organelle 38 23 5.4E-03 
GO:0043228 non-membrane-bounded organelle 38 23 5.4E-03 
GO:0044444 cytoplasmic part 84 65 7.1E-03 
GO:0031012 extracellular matrix 5 10 7.1E-03 
GO:0032991 macromolecular complex 56 40 9.4E-03 
GO:0005578 proteinaceous extracellular matrix 4 9 1.0E-02 
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Table A2.6 – Cellular Component – down-regulated genes 
GO  Name Expected Actual Fisher   
p-value 
GO:0005813 centrosome 5 16 2.7E-06 
GO:0005815 microtubule organizing center 5 16 1.5E-05 
GO:0032991 macromolecular complex 51 31 6.4E-04 
GO:0030529 ribonucleoprotein complex 12 2 1.4E-03 
GO:0044430 cytoskeletal part 15 27 1.9E-03 
GO:0044421 extracellular region part 11 2 2.0E-03 
GO:0044428 nuclear part 37 21 2.4E-03 
GO:0042995 cell projection 12 3 4.7E-03 
GO:0005730 nucleolus 13 4 5.0E-03 
GO:0031966 mitochondrial membrane 8 1 7.3E-03 
GO:0005875 microtubule associated complex 2 6 7.5E-03 
GO:0005615 extracellular space 10 2 8.6E-03 
GO:0000267 cell fraction 20 9 9.6E-03 
GO:0043234 protein complex 40 26 1.0E-02 
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microscopy/imaging, Xenopus embryo culture, microinjection, 
microarray fabrication and analysis (spotted 
cDNA/oligonucleotide), high throughput screening, robotic sample 
preparation, laboratory information management (LIMS). 
 
Bioinformatics Next-gen sequencing: mapping, alignment, RNA-Seq, ChIP-Seq, 
CLIP-Seq, targeted resequencing, SNP identification, alternative 
splicing modeling. Experience with SOLiD and Illumina datasets. 
 
Microarray analysis: cDNA array design and analysis, Affymetrix 
GeneChip analysis. 
 
Gene identification, orthology, and ontology classification and 
prediction 
 
HPC cluster administration and programming (Torque/PBS) 
 
Programming languages and computing environments 
Languages Python, Java, Bash, JavaScript, HTML, CSS, C++, C, PHP, Perl, R 
(in order of skill) 
Libraries / tools Numpy, Matplotlib, rpy (Python) 
   Hibernate, Spring, Guice, Servlets, JSP, Ant (Java) 
   MySQL 
Operating systems Mac OS X, Linux (various flavors),  
Microsoft Windows  
 
